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Molecular imaging holds considerable promise for elucidating biological processes in normal physiology as
well as disease states, by determining the location and relative concentration of specific molecules of interest.
Proton-based magnetic resonance imaging (1H MRI) is non-ionizing and provides good spatial resolution for
clinical imaging, but lacks sensitivity for imaging low-abundance (i.e., submicromolar) molecular markers of
disease, or environments with low proton densities. To address these limitations, hyperpolarized 129Xe NMR
spectroscopy and MRI have emerged as attractive complementary methodologies. Beyond hyperpolarization,
a 107-fold signal enhancement can be achieved by using novel indirect detection schemes (namely, Hyper-
CEST), showing great potential to meet the sensitivity requirement in many applications.
The concept of using 129Xe NMR for biosensing was first proposed by a Berkeley team in 2001 to realize
targeted imaging and biological sensing at a molecular level. The development of xenon biosensors has since
focused on modifying organic host molecules (e.g., cryptophanes) via diverse conjugation chemistries, and
has brought about numerous sensing applications including detection of chemical modifications,
oligonucleotide hybridization, enzyme active-site binding or enzyme-mediated proteolysis, and peptide
binding events. Designs for new 129Xe NMR biosensors have recently extended beyond cryptophanes to new
xenon-interacting scaffolds.
The expanded palette of 129Xe NMR biosensors now includes synthetic cryptophane and cucurbit[6]uril
constructs, as well as genetically-encoded gas vesicles and single proteins. In 2015 our lab first reported the
Hyper-CEST capability of cucurbit[6]uril, and this molecule has received additional attention in the past year
due to its commercial availability and excellent Hyper-CEST response. The ‘turn-on’ strategy reported by
both our lab and Pines provided a desirable alternative approach for biosensing. We also recently
demonstrated that TEM-1 β-lactamase can function as a single-protein reporter for hyperpolarized 129Xe
NMR, and observed useful saturation contrast for β-lactamase expressed in bacterial cells and mammalian
cells. These newly developed biosensors promise great potential in extending the scope of hyperpolarized
129Xe imaging towards molecular MRI, and efforts I made in these studies will be discussed in this thesis.
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ABSTRACT 
NEW BIOSENSING STRATEGIES USING HYPERPOLARIZED XENON-129 NMR 
SPECTROSCOPY 
Yanfei Wang 
Ivan J. Dmochowski 
Molecular imaging holds considerable promise for elucidating biological processes 
in normal physiology as well as disease states, by determining the location and relative 
concentration of specific molecules of interest. Proton-based magnetic resonance imaging 
(1H MRI) is non-ionizing and provides good spatial resolution for clinical imaging, but 
lacks sensitivity for imaging low-abundance (i.e., submicromolar) molecular markers of 
disease, or environments with low proton densities. To address these limitations, 
hyperpolarized 129Xe NMR spectroscopy and MRI have emerged as attractive 
complementary methodologies. Beyond hyperpolarization, a 107-fold signal enhancement 
can be achieved by using novel indirect detection schemes (namely, Hyper-CEST), 
showing great potential to meet the sensitivity requirement in many applications.  
The concept of using 129Xe NMR for biosensing was first proposed by a Berkeley 
team in 2001 to realize targeted imaging and biological sensing at a molecular level. The 
development of xenon biosensors has since focused on modifying organic host molecules 
(e.g., cryptophanes) via diverse conjugation chemistries, and has brought about numerous 
sensing applications including detection of chemical modifications, oligonucleotide 
hybridization, enzyme active-site binding or enzyme-mediated proteolysis, and peptide 
vi 
binding events. Designs for new 129Xe NMR biosensors have recently extended beyond 
cryptophanes to new xenon-interacting scaffolds.  
The expanded palette of 129Xe NMR biosensors now includes synthetic cryptophane 
and cucurbit[6]uril constructs, as well as genetically-encoded gas vesicles and single 
proteins. In 2015 our lab first reported the Hyper-CEST capability of cucurbit[6]uril, and 
this molecule has received additional attention in the past year due to its commercial 
availability and excellent Hyper-CEST response. The ‘turn-on’ strategy reported by both 
our lab and Pines provided a desirable alternative approach for biosensing. We also 
recently demonstrated that TEM-1 β-lactamase can function as a single-protein reporter for 
hyperpolarized 129Xe NMR, and observed useful saturation contrast for β-lactamase 
expressed in bacterial cells and mammalian cells. These newly developed biosensors 
promise great potential in extending the scope of hyperpolarized 129Xe imaging towards 
molecular MRI, and efforts I made in these studies will be discussed in this thesis. 
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CHAPTER 1 INTRODUCTION  
1.1 Physical properties of 129Xe 
Current techniques such as X-ray computed tomography (CT), positron emission 
tomography (PET); single-photon emission computed tomography (SPECT), and MRI are 
well established as powerful imaging methods with high spatial resolution and excellent 
tissue penetration ability. Compared to the other techniques, MRI, the clinical version of 
nuclear magnetic resonance (NMR), does not involve the use of ionizing radiation or 
radioactive tracer. However, traditional MRI lack molecular information that is valuable 
for early disease diagnosis. Although recent advances in the development of 1H MRI 
contrast agents have enabled stimuli-responsive detection of metabolites including 
enzymes, signaling molecules and pH values of local environments, they didn’t provide 
direct molecular detection with high sensitivity.1 The limitation on sensitivity arises 
because the signal in 1H MRI depends on the effect of contrast agents on thermally 
polarized 1H nuclei in the local environment, and as a result, at least high µM 
concentrations of contrast agents are needed.  
Hyperpolarized 129Xe NMR and MRI have emerged as attractive complements to 1H 
MRI, and have been investigated in many applications that require significant 
enhancements in detection sensitivity.2-5 The highly abundant isotope 129Xe possesses 
several advantageous physical properties that make it a unique candidate for molecular 
imaging. First, xenon is soluble in many solvents including organic solvents such as hexane 
and benzene, as well as aqueous solvents such as water, buffers, and blood plasma. As a 
result, xenon will uniquely partition between different solvents, or between blood and 
2 
tissue, and this feature can be specifically utilized for certain imaging applications. 
Secondly, the large and highly polarizable electron cloud of xenon affords high sensitivity 
to its local environment, translating to a large chemical shift window, approximately 250 
ppm,6 which compares favorably to a total chemical shift range of ~13 ppm exhibited by 
protons. Consequently, xenon can display very well-resolved chemical shifts, 
corresponding to the solvents it is dissolved in, or the small molecules and proteins it 
associates with. Thirdly, 129Xe can be hyperpolarized (hp) through a two-step process 
called spin exchange optical pumping where polarization is transferred from strongly 
polarized Rb electrons to 129Xe nuclei.7 The 129Xe NMR signal can be increased by more 
than 10000 fold in the hyperpolarization state. Therefore, very low concentrations of xenon 
can produce intense NMR signals. The sensitivity enhancement is supplemented by the 
fact that xenon doesn’t naturally exist in samples, and thus there is no competing 
background signal.  
Finally, for the purpose of in vivo imaging, hp 129Xe has considerably lower toxicity 
compared with paramagnetic metals currently used as contrast agents for proton-based 
MRI, and can be delivered to living organisms through inhalation or xenon solution 
injection. The long T1 of 129Xe in both gas phase and dissolved phase is beneficial because 
the hyperpolarization often happens outside the MRI detection region, and long T1 helps 
in sustaining the hp xenon signal after its transport from the hyperpolarizer to the detection 
region. It’s also worth noting that because signal averaging in hp MRI is not based on 
relaxation recovery but on renewed delivery of hp species for each scan, long T1 does not 
slow down image acquisition. These favorable properties of xenon have already led to 
many in vivo imaging studies, with the first example demonstrated by Albert et al., who 
3 
used xenon to image a mouse lung.8 Subsequently, there have been many examples of 
129Xe-based imaging of human lungs, chest and brain, which proved the biocompatibility 
of xenon-based MRI.  
1.2 Cryptophane-based xenon biosensors 
Xenon has low affinity for endogenous biomolecules, and will nonspecifically interact and 
participate into various microenvironments, based on the respective affinities, after being 
introduced into a biological system. In order to utilize 129Xe NMR to detect specific target 
molecules, it has been necessary to develop xenon-encapsulating agents that can both bind 
xenon and interact with target molecules. Fortunately, chemists working on host-guest 
systems had already discovered that cryptophane-A binds xenon strongly (KA ≈ 3000 M-1 
in C2D2Cl4) and reversibly, and that exchange of xenon in and out of cryptophane-A is 
sufficiently slow to give well separated xenon signals on a NMR spectrum.9,10 Other host 
candidates with modest room-temp xenon association constants include: hemicarcerand 
(KA ≈ 200 M-1), α-cyclodextrin (KA ≈ 20 M-1), and calix[4]arene derivatives (KA ≈ 14 M-
1).11-13 
Early work on syntheses of cryptophanes and studies of their complexation with 
xenon was extensively reviewed by Brotin and Dutasta.14 In 2011, we reported a shorter 
six-step synthesis of trifunctionalized cryptophane-A derivatives with an improved yield 
of 6%,.15 building on the work of Brotin et al. who reported a milder Sc(OTf)3 cyclization 
for cyclotriguiacylene formation.16 The use of either tripropargyl cryptophane with azide-
alkyne cycloaddition or trihydroxy cryptophane with amide coupling affords a facile means 
of functionalizing the cryptophane with solubilizing or targeting moieties. Our tri-
4 
functionalized cryptophanes -- triacetic acid cryptophane-A (TAAC),17 tris-(triazole 
propionic acid) cryptophane (TTPC),18 and tris-(triazole ethylamine) cryptophane 
(TTEC)19 -- show similar water solubility to the reported hexa-functionalized 
cryptophanes20 and exhibit significantly better xenon-binding affinities (KA =17000-42000 
M-1). We postulate that cation chelation by the six carboxylates may block xenon entry and 
also stabilize water inside the cavity.21 
In 2010, we investigated the interactions between cryptophanes with different 
pendant groups and guest molecules by X-ray crystallography. Co-crystallization of 
cryptophane-A, tripropargyl cryptophane and triallyl cryptophane with methanol, xenon, 
and chloroform revealed that the cavity internal volume (80–102 Ǻ3) varied with guest 
size.22 Importantly, we observed that in the xenon-bound structure, van der Waals 
interactions were nearly optimized, with an interior cavity volume of 85-89 Å3 and guest: 
host volume ratio of 0.47-0.49.  
The cryptophane itself has also been varied by altering the length of the linkers 
between the two cyclotriveratrylene caps, for example, cryptophane with one carbon 
between the two caps displayed an increased association constant with xenon20,23,24. Most 
recently, our collaborators in the Saven lab applied molecular simulation and free energy 
perturbation methods to estimate the affinities of Xe for six water-soluble cryptophanes, 
varying in both linker length and pendent groups.21 The simulations showed that 
displacement of confined water from the host interior cavity is a key component of the 
binding equilibrium, and the average number of water molecules within the host cavity is 
strongly correlated with the free energy of Xe binding to the different cryptophanes. 
5 
The specific targeting ability is achieved by attaching a target-binding moiety to the 
cryptophane via various conjugation chemistry, thereby generating a biosensor. They 
usually function by producing a different 129Xe chemical shift when bound to the target, 
due to the highly sensitive response of xenon to its local environment. The first 
cryptophane-based biosensor, developed by Pines and coworkers in 2001, had a 
cryptophane-A molecule modified for covalent attachment to a peptide as the solubilizing 
element and biotin as the targeting element.25 A significant shift, ~2.3 ppm, was observed 
for xenon in the cryptophane when bound to avidin. In their follow-up study, one resonance 
was observed for mono-allyl-substituted cryptophane-A, but upon conjugating the 
cryptophane with a chiral peptide two peaks that were 0.15 ppm apart appeared,26 which 
were attributed to the diastereomers. After the cryptophane was further derivatized with 
the biotin linker through maleimide chemistry a new racemic chiral center was formed, 
generating four bound peaks. The observed sensitivity of xenon to diastereomerism is 
problematic for many biosensing applications, because it dilutes the xenon-biomarker 
signal, and complicates peak assignments as well as efforts to selectively irradiate 129Xe in 
a specific environment, as required for many NMR experiments. 
Since then there have been numerous cryptophane-based biosensors described in the 
literature. Our laboratory demonstrated the ability of hp 129Xe to report on an enzyme 
cleavage event by appending cryptophane with a peptide substrate for matrix 
metalloproteinase-7, a known cancer biomarker.27 In a next study, Dutasta, Berthault, and 
others, utilized enantiopure cryptophane-A that was grafted with a 20-mer oligonucleotide 
to detect DNA binding.28 The 129Xe NMR peak for biosensor plus complementary strand 
was shifted 1.5 ppm upfield, and only one bound peak was exhibited, as expected for single 
6 
enantiomers. However, when increasing the concentration, both the biosensor alone and 
the biosensor plus noncomplementary strand exhibit multiple Xe@biosensor peaks. This 
was hypothesized to be a result of increased microemulsions and micelle/vesicle formation 
at higher concentration.28 This observation highlights the importance of developing highly 
solubilized xenon biosensors. Most recently, Kotera et al. attached hexa-carboxylate 
cryptophane to two arsenic moieties capable of interacting with proteins that contain a 
tetra-cysteine tag, and observed a single peak that was shifted 6.4 ppm upon addition of an 
excess of a Cys4-taged peptide.29 
Building on our earlier work using mono-functionalized cryptophane with a linear 
(RGD)4 repeat,30 we functionalized tripropargyl cryptophane with a cyclic peptide 
RGDyK, known to have high affinity and specificity for αvβ3 integrin, and two 3-
azidopropionic acids.31 We observed only one 4.1 ppm downfield-shifted peak when the 
biosensor bound to αvβ3 integrin, indicating that using a well-solubilized cryptophane, it 
was possible to engage protein targets using short tethers and still obtain well-resolved 
129Xe NMR spectra. Moreover, in order to investigate the cell compatibility of xenon 
biosensors we fluorescently labeled our cRGDyK-cryptophane and performed cell uptake, 
viability and specificity studies.31 The MTT assay demonstrated 60% viability at 75 µM 
biosensor for three cell lines. Confocal microscopy studies with the cancer cell line AsPC-
1, and normal human fibroblasts HFL-1, showed preferential biosensor uptake in AsPC-1. 
This work demonstrated targeting of αvβ3 integrin and αIIbβ3 integrin with nanomolar 
affinity and specificity and low cytotoxicity at concentrations required for NMR 
experiments, which paved the way for cellular NMR spectroscopy and imaging 
experiments that are now underway in several laboratories.32-34  
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We have used carbonic anhydrase II (CAII) and CAI, cytosolic isoforms of α-CA, as 
the archetype to guide the development of xenon biosensors.17,35 The unique 129Xe NMR 
chemical shifts for biosensors bound to CAI or CAII demonstrate the potential of xenon 
biosensors to discriminate between isoforms of α-CA. It is expected that CAIX and CAXII 
will also report characteristic 129Xe chemical shifts upon binding xenon biosensor, thereby 
allowing for the selective detection of these isoforms. 
The development of Hyper-CEST has greatly improved the detection sensitivity of 
129Xe NMR. In Hyper-CEST, host-encapsulated hyperpolarized 129Xe is selectively 
depolarized by radiofrequency saturation pulses, and the depolarized 129Xe rapidly 
exchanges with hyperpolarized 129Xe in aqueous solvent, where Xe is soluble and loss of 
signal is readily observed. The details of this technique will be described in Chapter 2. 
Since its development in 2006, Hyper-CEST has been applied in many biosensing 
applications. In 2009, Schlundt et al. modified cryptophane with a hemagglutinin peptide, 
which binds to a major histocompatibility complex protein, and observed a 1 ppm 
downfield shift. More recently, Schröder and coworkers acquired Hyper-CEST MR images 
of cell-internalized fluorescein-bearing cryptophane conjugates,32 of a peptide-
functionalized liposomal carrier targeting brain endothelial cells,36 and cells targeted by 
antibody-based modular biosensors.37 
Employing Hyper-CEST technique, our laboratory recently developed a 129Xe 
biosensor that undergoes a peptide conformational change and labels cancer cells at acidic 
pH. (Chapter 3) The biosensor was constructed by attaching a cryptophane host molecule 
to a 30mer EALA-repeat peptide that is alpha-helical at pH 5.5 and disordered at pH 7.5. 
The 129Xe NMR chemical shift at rt was strongly pH-dependent (Δδ = 3.4 ppm): δ = 64.2 
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ppm at pH 7.5 vs. δ = 67.6 ppm at pH 5.5 where Trp(peptide)-cryptophane interactions 
were evidenced by Trp fluorescence quenching. Using Hyper-CEST, we probed peptido-
cryptophane detection limits at low-picomolar (10-11 M) concentration. Furthermore, in 
biosensor-HeLa cell solutions, peptide-cell membrane insertion at pH 5.5 generated a 13.4 
ppm downfield cryptophane-129Xe NMR chemical shift relative to pH 7.5 studies.38 The 
larger separation of the two resonances was induced by the insertion of cryptophane into 
lipid membrane, which was observed and investigated in several other studies as well.32-34 
This attribute has also enabled the use of hp xenon and cryptophane to investigate the 
dynamic parameters of phospholipid membranes.39 
1.3 Hyperpolarized xenon in biomaterials 
Before its first use in biosensing, 129Xe had long been employed as a powerful probe to 
determine properties of microporous solids,40,41 such as zeolites, clays, metal-organic 
frameworks and microporous carbons.42 The chemical shift of 129Xe is dependent on both 
physical properties and chemical factors of the material, such as the composition of the 
matrix, the shape and size of void spaces, nature and concentration of co-adsorbed 
molecules. Over the past three decades, the application of 129Xe NMR in this field has 
evolved from determining the pore structure of a perfect zeolite, to studying the mechanism 
of the synthesis during crystallization of the zeolites, characterizing structural defects and 
interaction between cations in zeolites and adsorbed species.43 Functionalized zeolite has 
also been investigated for in vivo 129Xe MRI.44 
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Hyperpolarized xenon has been used alone to characterize biological environments 
and events as well. The first example by Albert et al. showed that xenon in the presence of 
red blood cells gave rise to two signals in the NMR spectrum.45 The ~20 ppm separation 
between two peaks was attributed to the interaction of xenon with hemoglobin present in 
the intercellular compartment of RBC.46 In 2011, Berthault and coworkers reported the 
129Xe spectra of many other cell types, including prokaryotic, eukaryotic, vegetal and yeast 
cells, where two signals, separated by only a few ppm at high cell density (107-108 
mammalian cells/ mL), were observed for all cell types, except for red blood cells.47  
In 2014, our laboratory employed Hyper-CEST to detect Bacillus anthracis and 
Bacillus subtilis spores in solution, and interrogate the layers that comprise their 
structures.48 (Chapter 4) Our study found that removal of the outermost spore layers in B. 
anthracis and B. subtilis (the exosporium and coat, respectively) enhanced 129Xe exchange 
with the spore interior, and therefore increased the Hyper-CEST saturation contrast. The 
mutant strains of both B. anthracis and B. subtilis, having less layers but not differing 
significantly from wild type in morphology, produced higher saturation transfer efficiency. 
In this example, the most Xe-accessible spore sample (strain AD142) was detected at a 
concentration of just 105 cfu/mL. Notably, the spores were invisible by hp 129Xe NMR 
direct detection methods, highlighting the lack of high-affinity xenon-binding sites, and the 
potential for extending Hyper-CEST NMR structural analysis to other biological and 
synthetic nanoporous structures.  
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1.4 Cucurbit[6]uril based xenon biosensors 
The cryptophane-based biosensors suffer from the difficulty of their multi-step synthesis 
and low yield. New xenon-binding contrast agents are needed to expand applications of hp 
129Xe in chemical sensing and biomedical imaging. Stevens et al. reported a 
perfluorocarbon nanoemulsion contrast agent for 129Xe NMR, with each droplet 
encapsulating multiple xenon atoms, depending on the sizing of droplets.49 In this study, 
nanoemulsions with droplet diameters between 160 and 310 nm were detected at 
concentrations as low as 100 fM, using Hyper-CEST. The perfluorocarbon nanodroplets 
were later shown to be internalized by cells, and detected sensitively.50 
Our laboratory found that commercially available cucurbit[6]uril (CB[6]) with a 
cavity that is hydrophobic, rigidly open, and of similar dimensions to Xe (diameter ≈ 4.3 
Å), can promote rapid Xe exchange interactions, as required by Hyper-CEST.51 (Chapter 
5) The hp 129Xe NMR spectrum obtained with 5 mM CB[6] using a direct detection method 
showed that the 129Xe-CB[6] peak in pH 7.2 PBS was 72 ppm upfield-shifted from the 
129Xe-water peak. We also measured thermodynamic and kinetic parameters associated 
with the complexation of xenon by CB[6]. Xe affinity determined for CB[6] in PBS at 300 
K was ~40-fold lower than measured previously for TAAC.18 However, the 129Xe-CB[6] 
exchange rate was ~17-fold higher than previously measured for 129Xe-TAAC (kexch = 86 
s-1) at 300 K,52 yielding very efficient magnetization transfer, which is favorable in Hyper-
CEST technique. Ultrasensitive indirect detection of CB[6] was achieved by applying 
shaped RF saturation pulses at the chemical shift of 129Xe in CB[6], and measuring the 
residual aqueous 129Xe signal after spin transfer as on-resonance CEST response. 
Remarkably, 1.8 pM CB[6] was readily detected in PBS at 300 K.  
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CB[6] is not readily functionalized for targeted sensing applications. Thus, we sought 
to exploit the versatile host-guest chemistry of CB[6] to develop a de novo “molecular 
relay” that reports on specific proteins in solution.53 (Chapter 6) We recently described 
CB[6]-based 129Xe NMR biosensors programmed for three sequential recognition events: 
a two-faced guest (TFG) initially binds CB[6], TFG is sequestered by cognate protein 
thereby freeing CB[6], and, lastly, xenon binds CB[6] for ultrasensitive detection by 
Hyper-CEST. The TFG is engineered to control this relay, such that CB[6]-129Xe NMR 
signal is absent until addition of analyte. In our initial proof of concept study, we designed 
four TFGs with a CAII-binding p-benzenesulfonamide moiety and CB[6]-binding 
butylamine tail, while varying the length and chemical structure of the linker. The TFG 
with highest affinity for CAII and intermediate affinity with CB[6] (TFG 4) was selected 
for testing our “turn-on” 129Xe NMR biosensing strategy. Upon addition of excess TFG 4 
to CB[6], the 129Xe-CB[6] signal was greatly reduced as a result of less free CB[6] in the 
sample solution. Subsequently, when CAII was added to the solution, 129Xe-CB[6] Hyper-
CEST signal was mostly restored, confirming that TFG 4 was sequestered by CAII. We 
also investigated the possibility of using our molecular relay in cellular environments, 
which highlights the ability of the CB[6] detection scheme to identify a specific protein 
target within a complex mixture.  
CB[6] has gained continued attention for its excellent Hyper-CEST response, 
comparable to previously used cryptophane constructs. For example, in 2015, Schröder et 
al. reported an enzyme-sensing platform based on a competition between 129Xe and an 
enzyme product for binding of the CB[6] cavity.54 Most recently, the Pines group designed 
a chemically activated CB[6]–rotaxane platform where the stopper component of a 
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rotaxane prevents 129Xe from accessing the CB[6] cavity.55 And only when a specific 
cleavage event occurs, CB[6] is released to produce a 129Xe@CB[6] signal. 
Previous cryptophane-based biosensing strategies mostly rely on small chemical 
shift differences between bound and unbound xenon sensors, which requires high spectral 
resolution that can be challenging in the Hyper-CEST setup. The turn-on strategy reported 
by both our lab and Pines lab provides a desirable alternative approach, which is to suppress 
the 129Xe@host signal completely until the sensor reaches a region of interest, or is 
selectively activated. Future efforts in our lab will focus on manipulating CB[6] for diverse 
applications in NMR and MRI detection.  
1.5 Genetically encoded protein as a 129Xe NMR reporter 
There has been a long-standing interest in developing genetically encoded MRI reporters 
that could combine the high-resolution non-invasive imaging technique with the power of 
molecular biology to visualize specific molecular processes. However previous efforts to 
develop such reporters for 1H MRI have been limited by low detection sensitivity.56 This 
has motivated investigation of Hyper-CEST contrast agents which can provide Xe-specific 
information within the context of 1H NMR signals, with high sensitivity.  
In 2014, Shapiro et al. reported the use of genetically encoded bacterial gas vesicles 
(GVs) as ultrasensitive Hyper-CEST contrast agents, detectable at picomolar 
concentration.57 The expressible reporters in this study are based on gas-binding protein 
nanostructures expressed by certain buoyant microorganisms. This study provides a 
pioneering example in developing a Hyper-CEST gene reporter, however it’s 
translationally challenging because GVs are very large (0.1 – 2 µm long) multimeric 
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protein assemblies from complex gene clusters, and difficult to reconstitute in many 
eukaryotic systems. 
Our lab has endeavored to develop a genetically-encoded single protein as a Hyper-
CEST reporter. (Chapter 7) We targeted a candidate protein TEM-1 β-lactamase (bla) 
based on its well-established allosteric site whose size and hydrophobicity suggest it to be 
a good target for Xe exchange. We observed two saturation responses in the Hyper-CEST 
z-spectrum for 80 µM bla: one free 129Xe in solution peak centered at 195 ppm, and a 
second peak centered at 255 ppm that was attributed to xenon-bla interaction. Both peaks 
in the Hyper-CEST z-spectrum appeared broad, indicating that xenon undergoes fast 
exchange between the aqueous state and transient protein-binding state. Importantly, the 
unique 129Xe-bla peak cannot be directly observed by hp 129Xe NMR spectroscopy even 
with high-concentration (~mM) bla, due to the low xenon-bound population and high rate 
of xenon exchange between different sites. We also carried out Hyper-CEST measurements 
by varying saturation time to determine the molecular sensitivity of bla, and showed that 
0.1 µM (2.9 µg/mL) bla was able to produce 0.23 ± 0.02 saturation contrast. The in vitro 
detection limit of single protein bla is comparable to previously reported GVs in terms of 
protein mass concentration,57 and represents a roughly 100-fold improvement compared to 
1H-CEST reporter genes.58 
We then investigated the possibility of using bla as a genetically encoded 129Xe NMR 
reporter in cellular environments. BL21(DE3) E. coli cells expressing recombinant wt-bla 
were induced with isopropyl-β-thiogalactopyranoside, and Hyper-CEST experiments 
showed a saturation contrast of 0.72 ± 0.03 for cells at OD600 of 9.2. After 6.7 sec of nearly 
continuous irradiation of 129Xe-bla with saturating radiofrequency pulses, the 129Xe-aq 
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peak was almost completely saturated. By contrast, the on-resonance and off-resonance 
curves were almost identical for the control E. coli sample at the same OD600. We also 
tested whether bla can function in mammalian cells, and found 0.2 million/mL transfected 
HEK cells producing the equivalent of 0.7 µM bla in the cell suspension was sufficient to 
produce a saturation contrast of 0.13 ± 0.01, compared to minimal contrast observed for 
control HEK cells. 
This study highlights a potential use for hp 129Xe as an ultrasensitive probe for 
studying cryptic pockets in proteins. Moreover, bla has been well established as a 
fluorogenic reporter for in vivo studies, which lends support to its further development as 
a Hyper-CEST reporter for biomolecular imaging. Efforts are underway to realize this 
potential: For example, bla mutagenesis should make it possible to increase Xe affinity at 
the primary site and also shift the Hyper-CEST response peak, either to achieve 
multiplexing or to discriminate against 129Xe-mammalian cell background signals.  
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CHAPTER 2 THEORY AND METHODOLOGY 
2.1 Theoretical basis for NMR signal 
A comprehensive quantum mechanical description of NMR has been reviewed at length 
by many authors, including Ernst59, Keeler60, Levitt61. Instead of a full overview of NMR, 
only the details directly relevant to this thesis will be presented here. 
2.1.1 Nuclear magnetization  
Nuclear spins in a magnetic field have a slight preference for populating the lower energy 
state over the higher one, with energy 
ܧ ൌ 	െߤ ∙ ܤ ൌ 	െߛ԰ܫ௭ܤ଴                                                                                               (2.1) 
where B0 is the external magnetic field applied along the z-axis; γ (in rad/sec) is the 
gyromagnetic ratio, an intrinsic property of the nucleus; ԰ is Planck’s constant divided by 
2π; Iz represents eigenvalues of the operator for the z-component of the angular momentum. 
A spin I > 1/2 system has 2I + 1 observable states with Iz = -I, -(I+1) …(I-1), I. Therefore, 
nucleus with spin I = 1/2, for example 1H or 129Xe, has two spin states, Iz = ± 1/2. 
The preference for the lower energy state, although very small, gives rise to an initial 
net magnetization vector aligned with the external field, which can be characterized as 
ܯ଴ ൌ 	 ଵଶ	 ஽ܰߛ԰ܲ                                                                                                          (2.2) 
where ND is the number density of spins and P is the polarization of the sample, which is 
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defined as the population excess of one spin state over the other, normalized by the sum of 
the populations: 
ܲ ൌ 	ேഀ	ି	ேഁேഀ	ା	ேഁ                                                                                                                   (2.3) 
At thermal equilibrium, polarization is given by the Boltzmann distribution 
ܲ ൌ 	 ௘షಶഀ/ೖ೅ି	௘
షಶഁ/ೖ೅
௘షಶഀ/ೖ೅ା	௘షಶഁ/ೖ೅								                                                                                               (2.4) 
Because Δܧ ൌ 	ܧఉ െ	ܧఈ ൌ 	െ	ߛ԰ܤ଴ , using 1H as an example, which has ½ spin and a 
positive γ value, 
 ܲ ൌ tanhሺ	ఊ԰஻బ௞் ሻ                                                                                                             (2.5) 
For ߛ԰ܤ଴ ≪ ݇ܶ, P ≈ ߛ԰ܤ଴/݇ܶ. The magnet used for the work reported in this thesis 
(BioDRX 500 in Penn Chemistry NMR facility) has B0 of 11.7 T, and gives rise to 
polarization of just 40 parts per million for protons at 300 K. This highlights that a large 
magnetic field (B0) and number density of spins (ND) are required in order to have a 
detectable NMR signal, according to Equation 2.2. Typically, proton concentration at ~mM 
is detectable with moderate field strength.  
As discussed in Chapter 1, one major limitation for proton-based MRI is its low 
detection sensitivity, which arises from the intrinsic properties of nuclear spins. 
Hyperpolarization, a technique that can generate non-equilibrium conditions with higher 
than 10,000-fold enhancement over thermal polarization (Figure 2.1), offers a viable 
solution to the sensitivity problem, and will be discussed in more detail in Section 2.2. 
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2.1.2 Relaxation 
In NMR experiments, magnetization is usually detected by coils placed in the x-y plane, 
perpendicular to the magnetic field direction (z-axis) in the laboratory frame. Therefore, 
the initial magnetization must be tilted to have a x-y component to be detected, and this 
perturbation of the equilibrium can be achieved by applying a radiofrequency (RF) pulse. 
Once the spins are on longer at equilibrium, the magnetization will evolve as described by 
the Bloch Equation (18) 
ௗۻ
ௗ௧ ൌ 	ۻ	 ൈ γ۰                                                                                                               (2.6) 
After RF pulses are applied, the receiver coils start to pick up the transverse 
magnetization that oscillates at the resonance frequency of the nucleus of interest (Larmor 
frequency). However, this magnetization is always restored to equilibrium by relaxation, 
which usually has two components T1 and T2 relaxation. T1, or longitudinal relaxation, 
describes the tendency of the magnetization to return to equilibrium, while T2 or transverse 
relaxation refers to the loss of the net magnetization coherence in the x-y plane. In a high-
field magnet, T1 for protons in water is 3-5 seconds, and for 129Xe in aqueous buffer it is 
~70 seconds. When taking NMR measurements, the delay time in between experiments 
needs to be about 5 times the T1 value to ensure recovery of initial magnetization. However, 
in NMR experiments for hyperpolarized nuclei, T1 governs the time range during which 
experiments can be conducted before hyperpolarization is exhausted, instead of the 
repetition time. Mathematically, T1 and T2 are determined by 
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ܯ௭ሺݐሻ ൌ ܯ଴	ሺ1 െ ݁ି௧/ భ்ሻ                                                                                               (2.7) 
ܯ௫௬ሺݐሻ ൌ ܯ଴	݁ି௧/ మ்                                                                                                       (2.8) 
2.1.3 Relaxation mechanisms 
Relaxation happens due to interactions of spins with one another or with the environment. 
The random motions, particularly rotation, resulting from the thermal agitation of 
molecules and the collisions between them, render relaxation time-dependent. Specifically, 
T1 relaxation can be mediated by three mechanisms: paramagnetic species, the dipolar 
mechanism and chemical shift anisotropy. 
Examples of paramagnetic species include dissolved oxygen in solution and certain 
transition metal complex, such as lanthanide chelate. These species can promote relaxation 
due to the large magnetic moment of their electrons. In practice, to avoid losing 
hyperpolarization of 129Xe in this manner, the sample in an NMR tube is always degassed 
prior to pressurization with hyperpolarized 129Xe. On the other hand, the effects of 
paramagnetic metal ions on both resonance frequency and the relaxation rate of nearby 
129Xe nuclei could be utilized for specific sensing or imaging applications. For example, 
the chelation of different paramagnetic metal ions with DOTA attached to a cryptophane 
cage was recently reported to alter the chemical shift of caged 129Xe distinctively.62 
The dipolar mechanism exists because each single nuclear spin associates itself with 
a magnetic angular momentum which produces a magnetic field for the nearby spins to 
experience, while at the same time, it is experiencing the field created by other spins. This 
interaction is quantified by 
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ܴ஽ ൌ 	ߛଵଶߛଶଶ ଵ௥భమల                                                                                                                  (2.9) 
where γ1 and γ2 are the gyromagnetic ratios of the two nuclei involved and the r12 is the 
distance between them. Because the gyromagnetic ratio of 129Xe (11.841 MHz/T) is 3.6 
times lower than that of protons (42.576 MHz/T), this relaxation mechanism does not cause 
drastic depolarization for 129Xe. 
We can observe a unique set of chemical shift for a molecule because the magnetic 
field experienced by each nucleus is different than the applied pulse, thanks to the 
shielding/deshielding effects of the electrons in the molecule. Chemical shift anisotropy 
(CSA) describes that the magnetic field experienced by the nucleus also depends on the 
orientation of the molecule relative to the applied field. This additional magnetic field 
experienced by a nucleus is three dimensional and creates relaxation, whose size is usually 
specified by a three by three matrix. In solution-state 129Xe or 1H NMR, usually only the 
average chemical shift is observed because of the rapid molecular tumbling. However, in 
solid-state NMR, for example when studying 129Xe -zeolite systems, CSA-induced 
relaxation becomes paramount and has been explored extensively.63 
Lastly, the transverse magnetization, or coherence can be destroyed in two ways. 
First, local oscillating field causes individual spins to move towards a new direction, 
similar to the effect that a pulse has on spins, and thus the alignment of the spins is 
damaged. Note that the same oscillating field also promotes T1 relaxation. The second 
mechanism causes the spin vectors to precess at different Larmor frequencies, by having 
an inhomogeneous field. This contribution mechanism depends on the spectral density at 
zero frequency J(0), and it was determined that J(0) = 2τc.60 The spectral density J(ωx) is a 
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measure of the amount of molecular motion at frequency ωx, and τc is the rotational 
correlation time, which is the average time it takes for a molecule to end up at an orientation 
about 1 radian from its starting position. Furthermore, in a slow-exchange system, line 
width can be specified by 
Δν ൌ 	 ଵగ మ்                                                                                                                    (2.10) 
Therefore, the longer the rotational correlation time is, the faster the relaxation rate gets, 
which gives rise to a broader line width. This phenomenon guided the design of numerous 
biosensors, and was observed in many 129Xe NMR measurements for cryptophane 
conjugates, where both the size and length of pendant groups were varied. 
2.2 Laser-polarized xenon-129 NMR 
2.2.1 Spin exchange optical pumping 
There are three major approaches currently used for preparing an artificially high spin 
population difference: dynamic nuclear polarization (DNP), para-hydrogen induced 
polarization (PHIP) and spin exchange optical pumping (SEOP). The function and 
operation of SEOP7 setup has been optimized for production of hp 129Xe, and will be 
described here. SEOP functions by creating a non-equilibrium population of electronic 
spins and transferring this polarization to the nuclei of interest such as xenon-129 or 
helium-3. It was originally introduced in the 1960s64. The theory and applications of SEOP 
in the context NMR and MRI experiments have been reviewed by many authors.7,65 Figure 
2.2 describes the SEOP process. In the first step, circularly polarized light is used to pump 
a certain transition in an effective one-electron system such as an alkali metal. Most 
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polarizer setups, including ours, work with rubidium whose vapor pressure is high and the 
D1 transition can be driven by a 795 nm diode laser. Rb is heated in a glass cell to increase 
vapor atmosphere, and is exposed to a magnetic field of 1-10 mT to lift the degeneracy of 
the ms = ±1/2 states. The σ- light tuned at 795 nm traveling along the field selectively pumps 
the transition 52S1/2  52P1/2 with a spin flip from ms = +1/2 to mJ = -1/2, due to the 
conservation of angular momentum. When in the first excited state, frequent collisions 
between the electron and other gas molecules such as helium allow transitions between mJ 
= +1/2 and -1/2 states, resulting in an incoherent superposition, or J-randomization, of the 
two states. This J-randomization leads to an effective mixing and equal populations of the 
two excited states. Subsequently, the electron decays back to the ground state via 
quenching collisions with N2 molecules. This non-radiative quenching mediated by N2 (1 
ns) happens faster than the natural decay of the excited states (~30 ns), which helps to 
conserve the non-equilibrium population of electron spins in the ground state. The energy 
of excited states was dissipated among the many vibrational levels in the N2 molecule, 
instead of being released via radiative decay. As a result, the ms = -1/2 state was 
significantly overpopulated while ms = +1/2 state was continuously depleted by the laser. 
Polarization of the valence electron of rubidium is transferred to the xenon nucleus 
through collisional hyperfine interactions. When the gas pressure is low, long-lived van 
der Waals complexes are major contributors to the polarization transfer.66 However, under 
high pressure (multi-atmosphere) conditions, the dominating process was thought to be 
binary collisions between two spins that were close enough, which leads to spin transfer 
from Rb electron to 129Xe nucleus.7 
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2.2.2 Hyperpolarizer setup 
To prepare for SEOP, an optical cell is coated with octadecyltrichlorosilane (OTS) which 
consists of long hydrocarbons, to reduce relaxation through the interaction of hp 129Xe with 
the cell wall. A more detailed procedure was described by Woolley.67 Briefly, after being 
thoroughly cleaned and dried over flow of nitrogen, the cell was filled with a solution of 
OTS, chloroform and hexane with volume ratio of 0.1:25:100. The solution was left to bind 
the surface of the optical cell for 5 minutes. Unbound OTS was removed by three rinses 
with chloroform. Introducing Rb to the optical cell is performed in a glove box. The coated 
optical cell, an ampule of rubidium, tools to break the ampule, a Pasteur pipet and a heat 
gun were transferred into a glove box for the procedure. Rb inside the ampule is heated up 
to liquid phase, and transferred to the optical cell with a Pasteur pipet.  
In our home-built hyperpolarizer (Figure 2.3), diode laser (OptiGrate) is tuned to 
highest power output (~65W) and passed through a beam expander and a λ/4 wave plate. 
The alkali-metal Rb is embedded in a high pressure gas mixture (50 psi, 3.4 atm) composed 
of 1% natural abundance xenon, 10% nitrogen and 89% balancing helium.  
2.2.3 Delivery of hp 129Xe 
There are two ways to deliver hp 129Xe, serving different experimental purposes. The first 
is using a cryogenic separation technique68 to obtain a batch of hp xenon. In this method, 
a cold trap immersed in liquid nitrogen separates xenon (melting point 161.25 K) from the 
rest of the gas mixture as the gas stream flows through the optical pumping cell. The flow 
was retained for ~20 min at a rate of 0.5 SLM to allow for hp 129Xe ice accumulation, while 
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the rest of gas mixture flows out of the outlet. A permanent magnet around the cold trap is 
used to conserve the 129Xe ice polarization. The relaxation time of solid 129Xe is about 3 h 
at 77 K.69 Subsequent sublimation of the xenon ice by replacing liquid nitrogen around the 
trap with hot water generates hp 129Xe gas that can be either sealed in a plastic bag for 129Xe 
gas imaging or directed to a NMR tube with a J-Young valve for solution NMR 
experiments.  
Alternatively, the gas mixture can be directly delivered into an NMR tube within a 
magnet, without condensation of xenon. This continuous flow setup allows hp xenon to be 
repeatedly bubbled into sample solutions, and therefore is particularly useful when 
acquisitions of multiple spectra are required, such as in Hyper-CEST.  
2.3 Indirect detection of xenon-129 NMR contrast agents by Hyper-CEST 
The hyperpolarization of xenon makes it possible to observe signals from low 
concentrations of biosensors. When the concentration of biosensor is low compared to 
dissolved xenon, the dissolved xenon can act as a polarization reservoir if just the 
magnetization of caged xenon is excited during signal acquisition. This can be achieved by 
applying selective pulses when the resonances are well separated. With a 0.1-0.15 sec delay 
between excitation pulses, there is effectively full recovery of the caged xenon 
magnetization, and hence many acquisitions can be taken before the dissolved hp xenon 
pool is exhausted. This soft-pulse approach relies on signal averaging based on the 
exchange of xenon, and allows for detection of cryptophane down to low micromolar 
concentration. Specific pulse parameters will be discussed in context of individual 
experiments in the later chapters.  
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The detection sensitivity can be further improved by exploiting the exchange of 
xenon between cage and solvent, and monitoring the reduction of free xenon resonance 
when the bound xenon is saturated. The saturation transfer effects are significant given the 
relatively long T1 relaxation for the free xenon compared to the exchange rate. This 
technique was termed Hyper-CEST to reflect the reliance on the initial hp xenon signal, as 
well as the modulation by CEST effect. Specifically, the 129Xe@cage spin pool is saturated 
by frequency-selective RF pulses, and through chemical exchange, the saturated spins 
transfer to the large bulk xenon spin pool. Selective RF pulses were applied for a long 
period compared to the mean xenon residence time inside cryptophane-A (~30 ms at 298 
K), allowing for a single cryptophane molecule to saturate hundreds of xenon spins. This 
method improved the detection sensitivity of cryptophane-A to the nanomolar and 
picomolar range, without the need for long acquisition times.52,70 A similar approach that 
took advantage of the exchange between xenon in gas phase and solution phase was termed 
xenon transfer contrast (XTC).71 
The pulse sequence used in most Hyper-CEST experiments is shown in Figure 2.4. 
Multiple (L6) selective saturation RF pulses (sp6) were used to irradiate the bound xenon; 
meanwhile, Xe dynamically exchanged between bound sites and the free solution pool. As 
a result, depolarization is accumulated in the solution pool and detected by a 90-degree 
hard excitation pulse (p1). The molecular sensitivity is usually determined by comparing 
the residual aqueous 129Xe signal after on-resonance saturation pulses and off-resonance 
saturation pulses (Figure 2.5) have been applied for a prolonged time. 
CEST experiments with thermally polarized protons were first demonstrated by 
Balaban et al.,72 who observed saturation transfer in barbituric acid and 5,6-dihydrouracil, 
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leading to frequency-dependent reduction of water proton signal intensity. 1H CEST 
experiments suffer from the fact that 1H chemical shift range is relatively small and the 
exchange of labile protons is often too fast to observe two separate resonances. The small 
chemical shift range of diamagnetic CEST agents has been addressed by introduction of 
paramagnetic agents that produce larger chemical shift separation and thus allow for higher 
saturation power and detection of faster exchange.73 However, compared to Hyper-CEST, 
the shorter lifetime of the water bound to the lanthanide metal ion gives rise to broad 
saturation signals in the z-spectra and affords lower selectivity.  
Theoretical aspects of CEST aim at describing and quantifying the saturation transfer 
effects. For a spin system without scalar couplings, chemical exchange processes are 
commonly described by modified Bloch equations that include the exchange terms, often 
called the Bloch-McConnell equations.74 Due to the difficulty in obtaining exact analytical 
solutions even for a two-site exchange system, researchers often endeavor to obtain 
analytical or numerical solutions by making simplifying assumptions and 
approximations.75 Zaiss et al. also presented an approximate approach for the Bloch-
McConnell equations for the case of Hyper-CEST.76 The Lorentzian approximation allows 
for straightforward evaluation of experimental data.   
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Figure 2.1: Sketch illustrating the difference between thermally polarized and 
hyperpolarized Xe-129 NMR spectra. At thermal polarization, there is almost no net 
magnetization; while at hyperpolarization there is significant excess of one spin orientation.  
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Figure 2.2: Schematic for Spin-Exchange Optical Pumping process. In the first step, 
circularly polarized light in combination with a magnetic field enables selective 
depopulation of one sub-level of the Rb ground state. In the next step, collision processes 
enable hyperpolarization to transfer from Rb electrons to Xe nuclei. 
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Figure 2.3: Photo of home-built 129Xe hyperpolarizer. 
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Figure 2.4: Hyper-CEST detection diagram. In the pulse sequence, a train of dSNOB pulses 
was applied at bound xenon resonance frequency. Spectral information is encoded in the 
spectral sweep, as the spins exchange from bound xenon to the solution pool. Integration 
of the acquired solution signals gives a z-spectrum. 
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Figure 2.5: Diagram for on- and off- resonance pulses. Shaped on-resonance saturation 
pulses were applied at the chemical shift of 129Xe-host, and off-resonance pulses were 
applied at the opposite side of 129Xe-aq with the same frequency interval observed for Xe-
host and Xe-aq signals. The residual aqueous 129Xe signal after saturation transfer was 
measured and compared as CEST response. 
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CHAPTER 3 A CRYPTOPHANE-129XE BIOSENSOR FOR PH-DEPENDENT 
CANCER CELL LABELING 
Adapted with permission from Journal of the American Chemical Society, Brittany A. 
Riggle, Yanfei Wang, and Ivan J. Dmochowski, 2015, 137, 5542-5548. DOI: 
10.1021/jacs.5b01938.38  Copyright (2015) American Chemical Society. 
 
3.1  Background 
Magnetic resonance imaging and spectroscopy are versatile and commonly employed 
techniques for the diagnosis and staging of disease.77 The development of targeted and 
stimuli-responsive (i.e., “smart”) contrast agents improves the capabilities of MRI for 
molecular imaging.78 Targeted therapeutic and diagnostic imaging techniques are typically 
directed to one or more receptors associated with a disease state. However, in cancer, as a 
result of large natural variations between cells and the heterogeneous nature of tissue within 
a tumor, there is also need for more general biomarkers.79,80 For example, hypoxia and 
acidification occur in 90% of tumors and are key microenvironmental factors in 
progression and treatment resistance in solid tumors.81,82 Tumors have been shown to 
acidify their micro-environment to levels between 5.7-6.9 (from a normal pH of 7.4) to aid 
in metastasis, mutation rate, and viability.80,83,84 Therefore, being able to identify cells in 
acidic environments has practical importance in the design of cancer therapies and 
controlled-release drug delivery mechanisms. Additionally, acidic environments can 
mitigate the efficacy of weakly basic chemotherapeutics such as doxorubicin, necessitating 
methodologies to probe extracellular pH (pHe).85 Here, we present an ultrasensitive xenon-
based MR contrast agent that can identify and label cell populations based on their pHe. 
A variety of pH-responsive MR contrast agents have been designed, including Gd 
complexes,86,87 tunable micelle-encapsulated polymers and 19F compounds,88,89 Gd and 
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superparamagnetic iron oxide (SPIO) glycol chitosan,90,91 and CEST agents,92-98 among 
others. These probes show tremendous promise for measuring pH in solution but do not 
selectively label cells in acidic environments. Moreover, applications with these reagents 
are generally limited by relatively low detection sensitivity on a per-monomer basis (i.e., 
low mM). One strategy for improving NMR detection sensitivity involves the use of 
exogenously supplied hp nuclei, e.g., 129Xe, 13C, and 3He, with magnetic spin reservoirs 
that exceed the normal Boltzmann distribution by several orders of magnitude. Xe binds 
void spaces in materials and proteins, but shows highest affinity and useful exchange 
kinetics for cryptophane. Perturbation of the large (~42 Å3 volume) 129Xe electron cloud 
can produce significant nuclear magnetic chemical shift changes and results in a nearly 300 
ppm chemical shift window when bound to different cryptophanes in aqueous 
solution.23,24,99 In one proof-of-concept experiment, Berthault et al. decorated cryptophane 
with six carboxylic acids to create a pH reporter: unique chemical shifts were measured 
over the pH 3.5-5.5 range with a total Δδ of 3.55 ppm.100 However, solubility issues 
precluded work near neutral pH.  
Recent studies have moved xenon biosensing from buffer solutions to lipid 
membrane suspensions and living cells. Meldrum et al. discovered that cryptophane in 
association with a dilute suspension of sub-micron Intralipid vesicles yielded a 129Xe NMR 
peak that was shifted ~10 ppm downfield from the aqueous 129Xe-cryptophane peak;101 
similar results were later obtained with different lipid compositions.34 Klippel et al. 
subsequently performed hp 129Xe chemical exchange saturation transfer (Hyper-CEST) 
NMR spectroscopy and imaging studies in cells loaded with lipophilic cryptophane and 
found a similar 9-11 ppm downfield chemical shift change, likely due to membrane 
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association.102-104 These studies highlight the large 129Xe NMR chemical shift changes that 
can be achieved by engineering cryptophane-lipid membrane interactions.  
Building on these examples, we set out to develop an ultrasensitive 129Xe NMR 
contrast agent for labeling cells in acidic microenvironments. Recent work from our 
laboratory105 and elsewhere106-108 has demonstrated nM-to-pM detection of water-soluble 
cryptophane using Hyper-CEST NMR spectroscopy. Thus, Hyper-CEST NMR should 
enable ultrasensitive detection of cryptophane-labeled cells that reside in acidic 
environments, provided that cryptophane-cell interactions can be modulated over the pH 
range 5.5-7.5. 
We hypothesized that modifying cryptophane with an EALA-repeat peptide, 
WEAALAEALAEALAEHLAEALAEALEALAA,109 should modulate 129Xe NMR 
chemical shift in response to physiologic pH changes. By our strategy, 129Xe NMR 
chemical shift should vary both from pH-dependent peptide conformational changes as 
well as pH-dependent peptido-cryptophane-cell membrane association. We based the 
design on our previously reported tripropargyl cryptophane-A derivative (with two 
cyclotriveratrylene units tethered by three ethylene linkers),9 which should allow facile 
attachment of a pH-responsive peptide and also two water-solubilizing to mitigate the 
potential for cryptophane aggregation.103 The synthetic EALA-repeat peptide was inspired 
by hemagglutinin (HA), which membrane inserts in low-pH environments.109 The poly-
glutamic acid nature of the peptide elevates the pKa to around 6, resulting in a 
conformational change from random coil (pH 7.5) to mostly alpha helical (pH 5.5), over a 
biologically relevant pH range.110 As the glutamates are protonated, the EALA-repeat 
peptide becomes more helical and hydrophobic, and it inserts into lipophilic membranes.111 
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This pH-dependent membrane insertion has been used in living cells to facilitate 
endosomal escape of both nanocapsule and gene payloads.112-114 Thus, by appending to 
cryptophane a membrane-inserting EALA peptide, we endeavored to generate a xenon 
contrast agent capable of being “activated” in acidic cell environments to label cell 
membranes and give large 129Xe NMR chemical shift changes.  
3.2 Results and discussion 
The synthesis of tripropargyl cryptophane was performed in six non-linear steps with 
modifications to previously published methods,15 with an overall yield of 6.4%. The azido-
EALA-repeat peptide was prepared with standard Fmoc synthetic methods, and attached 
to the cryptophane via copper(I)-catalyzed [3+2] azide-alkyne cycloaddition (CuAAC). In 
the next step, a solubilizing linker, 3-azidopropionic acid, was added a second CuAAC. 
Electronic circular dichroism spectroscopy confirmed that azido-peptide 2 maintained pH 
sensitivity. For the water-soluble EALA-cryptophane (WEC), we also observed increase 
in EALA helicity, from 36% (pH 7.5) to 61% (pH 5.5). These data established that the 
peptide still undergoes a significant conformational change when conjugated to the 
cryptophane. 
3.2.1 129Xe NMR spectroscopy 
We initially performed hp 129Xe NMR studies to examine the sensitivity of the 
cryptophane-encapsulated 129Xe chemical shift to the nearby peptide conformational state. 
NMR samples were identically prepared at 30 μM concentrations in 10 mM sodium 
phosphate buffer. Repeated trials at 300 ± 1 K ([Xe] = 6.2 mM)115 with the WEC at pH 7.5, 
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6.5, and 5.5 gave reproducible chemical shifts (Figure 3.1). A single peak was observed at 
both pH 5.5 (67.6 ± 0.5 ppm) and pH 7.5 (64.2 ± 0.5 ppm), with a chemical shift difference 
of 3.4 ppm. The double peak observed at pH 6.5 (δ = 67.0 and 64.4 ppm) is indicative of a 
roughly 1:1 mixture of the WEC in the alpha-helical and more disordered conformation, 
consistent with the CD spectra. Interestingly, although the cryptophane itself is a racemic 
mixture of stereoisomers and the EALA-repeat peptide is chiral, we did not observe a pair 
of diastereomeric peaks at pH 7.5 or pH 5.5 as we reported for a previous peptide-
cryptophane xenon biosensor and has been seen for various racemic xenon biosensors 
complexed to protein active sites. We hypothesize that the two diastereomers provide a 
very similar environment for the bound xenon atom, and produce what appears to be a 
single 129Xe NMR peak at both pH values. In this case, the inclusion of solubilizing 
propionates promotes open, xenon-binding conformations of the cryptophane, regardless 
of peptide conformation. 
Direct 129Xe NMR measurements were carried out on a Bruker BioDRX 500 MHz 
NMR spectrometer (138.12 MHz frequency for 129Xe), using a 10-mm BBO NMR probe. 
Sample temperature was controlled by VT unit on NMR spectrometer to 300 ± 1 K. Eburp2 
shaped pulse was used to selectively excite Xe@pH sensor peak. Spectra were averaged 
over 16 scans. A delay of 0.5 s was given between scans to allow for xenon exchange.  All 
acquired NMR spectra were processed with 60 Hz Lorentz broadening. Chemical shifts 
were referenced to free xenon gas of 0 atm at 0 ppm. 
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3.2.2 Hyper-CEST 129Xe NMR 
To improve detection sensitivity with WEC over direct detection by nearly six orders of 
magnitude, we employed Hyper-CEST NMR spectroscopy. This indirect detection method 
took advantage of the exchanging 129Xe population between bulk aqueous solution and the 
xenon host molecule by selectively saturating the bound signal. Because of xenon 
exchange, the selective depolarization resulted in a concomitant signal loss from the 
129Xe@water peak, which was readily monitored (Figure 3.2). This signal was compared 
with a reference measurement where an “off resonance” saturation was applied to account 
for the natural self-relaxation of hp 129Xe@water over time.  
Using 33.8 pM WEC (pH 7.5, 310 K, [Xe] = 0.15 mM) indirect detection via Hyper-
CEST was performed by applying shaped radiofrequency saturation pulses at the chemical 
shift of the 129Xe@WEC resonant frequency and measuring the residual aqueous 129Xe 
signal for different saturation duration (Figure 3.3). WEC was observed to “catalyze” this 
depolarization process through on-resonance (64.2 ppm) saturation rf pulses with 
129Xe@WEC in pH 7.5 buffer. In contrast, saturation pulses applied off-resonance (320.6 
ppm) gave a depolarization time that approximated the natural T1 of hp 129Xe in water. 
We also investigated the pH sensitivity of WEC-hp 129Xe NMR chemical shift by 
using a 1-ppm saturation pulse to look at “normal” (pH 7.5) and acidic (pH 5.9) buffer 
solutions, Figure 3.4. Because the depolarization efficiency is decreased with the narrower 
saturation pulse, WEC was employed at 1 µM concentrations, which is still at least 103-
fold more dilute than demonstrated for 1H CEST pH reporters.116 Prior to detecting a free 
xenon signal, a loop of selective Dsnob-shaped saturation pulses was scanned over the 
chemical shift range of 40-230 ppm in 5-ppm (700 Hz) steps, which corresponded to pulse 
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length of 3748.6 µs and field strength of 77 µT. Two saturation responses centered at 195 
ppm (129Xe@H2O) and 65 ppm (129Xe@WEC) were observed. By decreasing the 
frequency scanning step size to 1 ppm (138.2 Hz), which corresponded to shaped pulse 
length of 19014 µs and field strength of 15 µT, we were able to distinguish the WEC-
encapsulated 129Xe peak for pH 7.5 and pH 5.9 samples at 300 K (Figure 3.4, inset). The 
total time to record the Hyper-CEST NMR spectra was composed of xenon delivery time 
(20 s) and data collection time (Figure 2.4). For the latter, each data point required time T: 
ܶ ൌ ሺݏ݌6 ൅ ݀6ሻ ∗ ܮ6 ൅ ݀1 ൅ ݌1 
In the 5-ppm step scanning experiments, sp6 (saturation pulse length) = 3.748 ms, 
d6 (delay between saturation pulses) = 20 µs, L6 (number of saturation cycles) = 400, d1 
(delay before acquisition pulse) = 0.5 s, p1 (acquisition pulse) = 22 µs. Thus, the total time 
needed to acquire the whole spectrum was 860 s. In the 1-ppm step scanning experiments, 
sp6 = 19.014 ms, L6 = 600, and the total time needed was 478 s. The observed ~2:1 ratio 
of peaks corresponding to alpha-helical/disordered peptide at pH 5.9 was consistent with 
hp 129Xe NMR data collected for 30 µM WEC by direct detection, where 1:1 ratio of alpha-
helical/disordered peptide was observed at pH 6.5 (Figure 3.1). As illustrated by these data, 
the Hyper-CEST 129Xe NMR spectrum readily distinguished between physiologically 
normal and acidic pH values. 
3.2.3 Cellular Hyper-CEST 129Xe NMR 
Finally, we investigated the utility of WEC in a biological setting through 129Xe-NMR cell 
studies. Human cervical carcinoma (HeLa) cells were grown in a flask to confluency. Cells 
were washed and suspended in either pH 7.5 or 5.5 sodium phosphate buffer containing 5-
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10 µM WEC to give 1 x 107 cells/mL concentrations. Pluronic L-81 (0.1% final conc.) was 
added to reduce foaming that can result from Xe bubbling. Cells were incubated in these 
conditions for 45-60 min and then transferred to an NMR tube. Spectra were acquired at 
both pH values with frequency scanning step size of 1 ppm (138.2 Hz), 400 cycles, which 
corresponded to shaped pulse length of 19014 µs and field strength of 15 µT. Figure 3.5a 
shows xenon internalized in cells (red trace) and xenon dissolved in aqueous solution of 
HeLa cells suspended in pH 7.5 buffer with WEC (blue trace). Figure 3.5b shows WEC-
encapsulated xenon in the same sample. 129Xe@WECaq, pH 7.5 gave a chemical shift of 
65.0 ppm, which corresponds to free biosensor in buffer at pH 7.5. In pH 5.5 experiments, 
Figure 3.5c shows two peaks, one for Xe@cells (red trace) and one for Xe@aq (blue trace). 
Figure 3.5d shows the biosensor region of the same sample and exhibits two peaks, one at 
68.0 ppm corresponding to free alpha-helical WEC in buffer (blue trace) and one at 78.4 
ppm that we assign to WEC inserted in cell membrane (red trace). Notably, upon biosensor-
membrane insertion at pH 5.5, we observed a 13.4 ppm downfield chemical shift compared 
to biosensor-cell solutions at pH 7.5. Contrary to previous 129Xe NMR cell studies 
performed with a more lipophilic cryptophane, we did not observe cryptophane-membrane 
association at pH 7.5.101 This result is also consistent with previous studies with the EALA 
peptide that showed no membrane association at pH 7.5.117 By targeting acidic pHe as a 
general cancer biomarker, along with membrane association, we increased the chemical 
shift difference between Xe@biosensorcells and Xe@biosensoraq as compared to earlier 
studies.32,102,103 
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3.3 Conclusions and future directions 
In summary, by attaching a pH-responsive, membrane-inserting peptide and two water-
solubilizing moieties to a tripropargyl cryptophane host, we were able to generate an 
ultrasensitive 129Xe NMR biosensor capable of labeling cells in acidic microenvironments. 
This xenon biosensor is unique for undergoing a reversible conformational change (over a 
range of physiologic pH values) as well as functional changes: at pH 5.5, the pendant 
EALA-repeat peptide was mostly alpha-helical and gained membrane-insertion 
capabilities. This represents a “smart” 129Xe MR contrast agent, and builds on 
previous examples of xenon biosensors that bind specific targets (e.g., protein 
receptors, DNA, cell-surface glycans) or undergo a modification event (i.e., enzyme-
mediated peptide cleavage).  
Significantly, this study demonstrated that appending the peptide to the ~1 nm 
diameter, hydrophobic cryptophane did not significantly reduce its ability to 
undergo a conformational change. Circular dichroism, Trp fluorescence, and hp 
129Xe NMR spectroscopies were employed to measure the change in helical 
character of the peptide in the pH range 5.5-7.5. EALA peptide helix formation 
resulted in a 129Xe NMR downfield chemical shift change of 3.4 ppm, which was 
likely enhanced by significant cryptophane interactions with the nearby, N-terminal 
Trp residue. This suggests a general strategy for engineering larger chemical shift 
changes in xenon biosensors, particularly to monitor molecular events occurring 
nanometers away from the xenon-cryptophane reporter. These data represent a 
significant advance over the previous example of a peptido-cryptophane biosensor, 
which monitored MMP-7 activity: only a 0.5 ppm chemical shift change was 
40 
observed upon enzyme-mediated peptide cleavage, perhaps because the Trp was 
positioned much farther from the cryptophane.27 Ongoing studies in our laboratory 
will help to elucidate the nature of the Trp-cryptophane interaction. 
More generally, these experiments highlight the utility of the hp 129Xe-
cryptophane reporter as a biophysical probe. Monitoring peptide (or protein) 
conformational changes with Hyper-CEST NMR requires only a single-site 
modification with cryptophane and may present significant advantages relative to 
FRET and other optical techniques with regard to detection sensitivity, particularly 
in turbid media. Picomolar (10-11 M) concentrations of WEC were detected by 
Hyper-CEST NMR, making this approach 8-9 orders of magnitude more sensitive 
than conventional MR contrast agents. 
With our long-range goal to develop ultrasensitive 129Xe MR contrast agents 
to aid in cancer diagnosis and treatment we employed an EALA peptide capable of 
membrane insertion at acidic pH.111,119 Pioneering studies in the Pines and Schröder 
laboratories have shown that cryptophane association with membranes induces 
significant downfield 129Xe NMR chemical shift changes.111,119 We exploited this 
property in designing the WEC biosensor, and demonstrated a 13.4 ppm downfield 
chemical shift from disordered-peptide biosensor at “normal” pH to the helical, 
membrane-inserted biosensor at pH 5.5. The development and cellular 
implementation of this “smart” xenon biosensor are important steps towards future 
biomedical applications.  
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Figure 3.1: Hyperpolarized 129Xe NMR spectra (average of 16 scans, line-broadening = 60 
Hz) of WEC (30 µM) in 10 mM sodium phosphate buffer at 300 ± 1 K, with peak widths 
(FWHM) indicated in Hz: a. pH 5.5, 211 Hz; b. pH 6.5, 317 and 214 Hz; c. pH 7.5, 154 
Hz. 
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Figure 3.2: Hyper-CEST detection scheme for WEC-encapsulated 129Xe. a. Representative 
spectra are shown for i. the initial spectrum and ii. the resulting spectrum from selective 
“on resonance” saturation of the WEC-encapsulated 129Xe and commensurate bulk 
129Xe@H2O depolarization; b. selective radio frequency depolarization of WEC-
encapsulated 129Xe.  
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Figure 3.3: Hyper-CEST signal decay with 33.8 pM WEC at pH 7.5, 310 K. Depolarization 
rates were measured with radiofrequency pulses either on-resonance (64.2 ppm) or off-
resonance (320.6 ppm) with hp 129Xe@WEC. 
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Figure 3.4: Hyper-CEST scan of WEC (1 µM) at 300 K. Full image was collected with 5-
ppm step and individual peaks with 1-ppm step at pH 7.5 and pH 5.9 (inset). 
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Figure 3.5: Hyper-CEST 129Xe NMR spectra for 5-10 µM WEC in 10 mM sodium 
phosphate buffer with 0.1% Pluronic L-81 in a suspension of 1 x 107 cells/mL. Data were 
collected at pH 7.5, a. Xe@cells-red trace, Xe@aq-blue trace; b. Xe@WECaq; and at pH 
5.5, c. Xe@cells-red trace, Xe@aq-blue trace; d. Xe@WECcells-red trace and Xe@WECaq-
blue trace. Exponential Lorentzian fits are shown as coloured, solid lines and the 
corresponding sums are shown as solid black lines. 
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CHAPTER 4 BACTERIAL SPORE DETECTION AND ANALYSIS USING 
HYPERPOLARIZED 129XE CHEMICAL EXCHANGE SATURATION 
TRANSFER 
Reproduced by permission of The Royal Society of Chemistry, Yubin Bai‡, Yanfei 
Wang‡, M. Goulian, A. Driks and I. J. Dmochowski, Chem. Sci., 2014, 5, 3197, DOI: 
10.1039/C4SC01190B.48 (‡ denotes equal contribution) 
 
4.1 Introduction  
Here, we demonstrate a 129Xe NMR spectroscopic method that allows both sensitive 
analysis and detection of intact bacterial spores in aqueous solution, without further 
sample preparation. NMR spectroscopy has been used previously to analyze spore 
contents but typically offers limited detection sensitivity, due to small polarization 
of the nuclear spin reservoir. This study highlights that Hyper-CEST NMR analysis 
of spore samples can be performed in the absence of cryptophane or other high-
affinity xenon-binding sites. 
A subset of bacteria produce a highly resistant, dormant cell type, called the 
spore, which is produced in response to specific stresses, most notably starvation. 
120-122 Although essentially metabolically dormant121 the spore can break dormancy 
(a process called germination) very soon after the spore detects signals that indicate 
conditions for resuming growth are present. A small fraction of spore-forming 
species are pathogenic, including Clostridium difficile, one of the most important 
healthcare-associated infectious agents122 as well as Bacillus anthracis, a major 
biothreat agent.123 The threat posed by these and other pathogenic species has 
intensified efforts to better understand the roles of spore structures in resistance, as 
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well as to improve methods of spore detection. The spore's unusual—and 
incompletely understood—structural integrity in the face of extreme temperatures, 
mechanical stress, chemical denaturation and other stresses is essential to 
maintaining viability as well as resisting host defense and decontamination.124 A 
molecular understanding of the protective structures encasing the spore has been a 
goal of basic research for many decades.125  
Spores have a distinctive architecture, composed of a series of concentric 
layers, each of which contributes to resistance and other spore properties (Figures 
4.1a, b). In some species, including B. anthracis, the outermost spore layer is the 
exosporium, a pleomorphic shell composed of proteins and glycoproteins (Figure 
4.1a). The exosporium is present in pathogenic and nonpathogenic species (for 
example, see Traag et al.126). Beneath the exosporium, and separated by a gap, is the 
coat, which is present in all bacterial spores (Figure 4.1b).125 Although these two 
layers play key roles in spore resistance, their chemical properties and molecular 
organization remain incompletely understood. This lack of information hinders 
efforts to improve anti-spore therapeutics, decontamination and spore detection. In 
particular, sensitive methods for spore detection that do not require major sample 
preparation and discriminate between pathogenic and nonpathogenic spore-forming 
species are needed. No existing method achieves all these goals, and distinguishing 
among even highly divergent species without DNA sequencing has been especially 
challenging. For example, fluorescence-based assays have been developed that 
readily detect bacterial spores,127-131 but cannot discriminate between species, 
because the target analyte, dipicolinic acid (DPA), is present in bacterial spores of 
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all species. Raman spectroscopy similarly identifies spores from dominant calcium 
DPA signals.132 Methods that identify subcellular structures in spores that vary 
among species (and, in particular, between certain pathogenic and non-pathogenic 
species) could be very helpful for improving pathogen detection. 
Recently, Liu et al. showed the ability to monitor the germination and 
proliferation of bacteria using 1H-CEST MRI, where labile protons inside the 
cytoplasm or on the cell surface served as endogenous contrast agent; however, 
bacterial spores were invisible by this technique, due to limited water accessibility 
within spores.133  
Here, we present Hyper-CEST 129Xe NMR analysis of wild-type and mutant 
B. anthracis and B. subtilis spores, where detection limits of 105-109 spores per 
milliliter were achieved in aqueous solution. 129Xe gas irradiated by radiofrequency 
pulses in the spore interior efficiently transfers loss of magnetization to the bulk 
solution, which provides contrast between different spore structural components. 
We analyzed strains of B. anthracis that vary in exosporium, or exosporium and coat 
structure and strains of B. subtilis that vary in coat structure. These strains show 
readily distinguishable Hyper-CEST behaviors, in a manner consistent with the 
hypothesis that spore layers cause variations in the rate of xenon diffusion between 
aqueous solution and the spore interior. By determining the Xe accessibility of the 
spore interior to the outer environment, Hyper-CEST NMR provides a rapid, 
nondestructive measure of molecular porosity. Importantly, this methodology 
distinguishes between spores with and without exosporia. As a result, in 
combination with other technologies, it provides a novel method for distinguishing 
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between different bacterial spores, and assigning structural-functional significance 
to different spore components.  
4.2 Experimental section 
4.2.1 Bacterial strains 
All strains are in either the attenuated Sterne strain 34F2 (for B. anthracis) or 
PY79134 (for B. subtilis) backgrounds. The B. anthracis strain RG56 lacks the 
exosporium and has a minor defect in the coat (due to a mutation in cotE) and strain 
Sterne-JAB-13 possesses the innermost layer of the exosporium (the basal layer) but 
lacks the hair-like projections (or nap) that project from the basal layer-outer 
surface.135,136 The B. subtilis strains AD28 and AD142 lack the outer layers of the 
coat, or almost the entire coat, due to mutations in cotE, or cotE and gerE, 
respectively.137,138 We note that while the genes named cotE in B. anthracis and B. 
subtilis are indeed orthologous, their mutant phenotypes have important differences 
between these two species, as described. 
4.2.2 Hyper-CEST experiment with spores 
Before starting the Hyper-CEST experiment, fresh hp 129Xe was delivered via 
bubbling through a 3-mL liquid sample contained in a 10-mm diameter NMR tube. 
Immediately before the pulse sequence (Figure 2.4) started, hp Xe bubbling was 
stopped by solenoid valves to stabilize the liquid sample for NMR acquisition. The 
NMR tube was airtight during the Hyper-CEST experiment, which was achieved 
with a homebuilt continuous-flow hp Xe delivery setup.52 
50 
Figure 4.1c illustrates the Hyper-CEST experiment involving spores. Pulse 
power was calibrated to give maximum saturation performance. Xenon resonances 
within the RF pulse’s selected frequency range (corresponding to the Xe-spore 
interaction) were depolarized. The ensuing chemical exchange accelerated 
depolarization of xenon in the whole sample, as measured by loss of Xe(aq) signal. 
After the overall polarization was reduced by saturation pulses and chemical 
exchange, the sample was irradiated with a 90-degree hard pulse to observe the final 
magnetization state of 129Xe in solution.  
4.3 Results and Discussion 
4.3.1 Hyper-CEST profile for spores  
Multiple (100-600) selective 180-degree radio-frequency pulses were delivered to 
spore samples at the various resonance frequencies, of duration between 1.0 s and 
9.5 s. By scanning the saturation frequencies, different Xe(aq) signal intensities were 
acquired and plotted as the exchange profile. At frequencies of observable Xe 
depolarization, hp Xe and depolarized Xe were dynamically exchanging among 
distinguishable chemical environments related to spores. 
Figure 4.2 shows the profile of wild-type B. anthracis at 1.2×109 cfu/mL, in 
the 188-203 ppm frequency range and at 0.5 ppm resolution. A Xe(spore) signal was 
observed to be actively exchanging with the Xe(aq) signal. After the profile was fit 
by Voigt line shape, two signals were identified (Figure 4.2a). The secondary peak 
at 196.3 ppm (7.6 ppm wide) was assigned to Xe(spore); while the main peak at 
193.4 ppm (4.5 ppm wide) was assigned to Xe(aq). Similar profiles were also 
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observed for all spore samples listed above, at much lower spore density of 1.2×107 
cfu/mL. The linewidth of the Xe(spore) peak appeared quite broad for all strains. 
We hypothesize that due to lack of high-affinity binding sites, the exchange rates 
between xenon and multiple exchange sites that reside at or near the dehydrated 
spore interior are fairly rapid, leading to the merged broad peak. The Xe(spore) peak 
chemical shifts are summarized in Table 4.1, which identify a similar Xe-spore 
interaction (196-199 ppm) across the different spore samples.  
4.3.2 Depolarization rate measurement for spores  
To compare the Hyper-CEST performances across spore strains, and to make the 
CEST effect more observable, the hp Xe depolarization background needed to be 
removed. Two frequencies, 197.5 ppm and 188.9 ppm, were selected for Hyper-
CEST ‘on’ and ‘off’ resonance, and kept the same in the two series of data points. 
The number of saturation pulses in the sequence was increased from 0 to 2000 in 
steps of 200 (Figure 4.2b), corresponding to saturation times between 0 s and 38 s. 
Meanwhile, the Xe(aq) signal decreased exponentially as more pulse power was 
applied to the sample. The exponential decay time (T1) of hp Xe, for the two selected 
frequencies, was extracted by fitting the decay curves. In Figure 2b, the decay time 
constants (T1) were fitted to be 16.5 s (on) and 29.6 s (off). The existence of chemical 
exchange with the ‘on resonance’ group greatly accelerated the decay rate. 
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4.3.3 Saturation transfer efficiency (Hyper-CEST contrast) 
We quantified the contrast generated by the Hyper-CEST experiment by computing 
the saturation transfer efficiency (ST), which is directly proportional to the MR 
image contrast: 
                                                                                       (4.1) 
In equation 4.1, I represents the integral of Xe(aq) signal acquired in a Hyper-CEST 
experiment with set saturation frequency, duration, and power. L represents the 
duration of Hyper-CEST pulse sequences, which is the sum of time spent in shaped 
saturation pulses and delays. The summing index k indicates the experiment number 
in Figure 4.2b, and k′ is the total number of experiments. Thus, ST is normalized to 
give values less than 1, and to give greater weight to the signals (indicating loss of 
polarization) obtained in the later experiments. This weighted sum, corresponding 
to ST, provides the proportion of saturation-transferred magnetization, over the 
initial value. Therefore, ST quantifies the efficiency of the Hyper-CEST experiment 
for each sample. 
4.3.4 Enhanced Hyper-CEST due to altered exosporium 
We analyzed one B. anthracis strain (RG56) lacking the exosporium due to 
inactivation of cotE and one missing the major exosporium protein BclA (Sterne-
JAB-13). B. subtilis spores lack an exosporium. In Table 4.1, ST is listed for all 
strains at 1.2×107 cfu/mL. Both B. anthracis spore variants gave dramatically 
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enhanced Hyper-CEST contrast compared to wild-type 34F2. Strain Sterne-JAB-13 
had strongly increased sensitivity to Hyper-CEST, with complete removal of the 
exosporium (in RG56) showing only a small additional enhancement. This is 
consistent with the interpretation that the hair-like projections on the exosporium 
surface create a significant barrier to xenon exchange. Significantly, wild-type B. 
anthracis (Sterne 34F2) was almost undetectable by Hyper-CEST at concentration 
of 107 cfu/mL, which gave rise to a ST value of nearly zero. In fact, 100-fold higher 
concentration (109 cfu/mL) was required for this strain to be readily detected (Figure 
4.2). 
4.3.5 Enhanced Hyper-CEST from B. subtilis spores with coat defects 
To determine whether Hyper-CEST can be used also to monitor the molecular 
features of the spore coat, we analyzed wild-type B. subtilis, and strains lacking the 
outer layers or almost the entire coat (strains PY79, AD28, and AD142, 
respectively). We found that in the absence of the outer layers of the coat, the Hyper-
CEST contrast was enhanced by more than 2-fold (comparing PY79 and AD28, 
Figure 4.3). Strain AD142 (lacking almost the entire coat) gave an additional 2-fold 
increase in Hyper-CEST contrast. We conclude that spores lacking coat layers are 
more sensitively detected by Hyper-CEST. We infer that this increase is due to the 
spore interior being more accessible to xenon in solution. To measure the limit of 
detection of the most Xe-accessible strain, we performed Hyper-CEST on strain 
AD142 at concentrations from 104 to 106 cfu/mL. Clear Hyper-CEST contrast was 
observable at 105 cfu/mL.  
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4.3.6 Possible origin of xenon exchange in spores  
With a ~4.3-angstrom diameter, and very polarizable electron cloud, Xe is known 
to exhibit affinity for sub-nanometer-sized void spaces in materials, proteins, and 
organic cages. 45,140,141 Xe is also very sensitive to its environment, as reflected by 
the ~4 ppm chemical shift difference between the Xe(aq) and Xe(spore) NMR peaks. 
Our data are consistent with xenon occupying hydrophobic sites in the largely 
dehydrated spore interior,141 where the chemical shift will differ from xenon in bulk 
water and result in a reservoir for exchange behavior. As highlighted above, spores 
with fewer outer layers presented stronger Hyper-CEST contrast. The best contrast 
was observed with strain AD142, which largely lacks the coat.142 This argues that 
the cortex, inner membrane and core are sites of Xe exchange.  
4.3.7 New approach for xenon biosensing 
Besides finding naturally existing xenon binding sites (i.e, hemoglobin46), many 
efforts in xenon biosensing have focused on developing small molecules5 or 
proteins143-145 with singular high-affinity xenon binding sites, but this remains a 
formidable challenge. Noteworthy are water-soluble cryptophanes, which bind a 
single xenon atom with modest affinity (KD = 25-200 M at rt); however, challenges 
in cryptophane synthesis and functionalization limit broad use for hp 129Xe NMR. 
The spore experiments suggest an alternate approach, to exploit xenon interactions 
with nanoporous structures in solution. As demonstrated here, Hyper-CEST NMR 
can reveal xenon interactions that are otherwise invisible using direct detection hp 
129Xe NMR methods. No “bound” 129Xe NMR signal was directly observed for any 
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of the spore samples at concentrations of 1.2×107 cfu/mL, which is consistent with 
the lack of high-affinity xenon-binding sites in the spore samples. By producing a 
Xe-bound resonance frequency that is detectable by Hyper-CEST NMR (via 
accumulated cycles of magnetization transfer in solution), the spores most likely 
possess a significant number of low-affinity Xe binding sites, with KA ≈ 10-100 M-
1; single Xe binding sites have been seen for many proteins.146,147 Additionally, the 
exchange rates must be fast compared to the timescale of the hp 129Xe longitudinal 
relaxation time (T1 ≈ 75 s) in order to produce the observed enhancement in 
sensitivity relative to direct detection schemes.  Many biological and synthetic 
structures should have the necessary size and porosity to achieve useful chemical 
exchange. 
Importantly, the variation in ST efficiency observed for the three B. anthracis 
strains and the three B. subtilis strains cannot easily be attributed to differences in 
gross morphology. None of the mutant strains differs sufficiently from wild type in 
their dimensions to account for the effects we detect.136,142 Hyper-CEST NMR 
provides a noninvasive method for probing interior spore structures that are 
otherwise difficult to assess at the molecular level. The current findings argue that 
the bacterial spore interior is accessible to small hydrophobic molecules of the size 
of Xe. Small molecules, such as methane, which differ somewhat from Xe in size, 
hydrophobicity, and diffusion rate, may also be able to penetrate through the spore 
protection layers, giving further opportunity to analyze the spore structure.  
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4.4 Conclusions and future directions 
We have successfully analyzed various bacterial spores using a sensitive Hyper-
CEST NMR technique. The ability of Xe to diffuse readily within the spore layers 
and interact with the interior to give rise to Hyper-CEST signal‒without cryptophane 
or other engineered binding sites‒suggests many new applications for Hyper-CEST 
NMR in studying nanoporous structures commonly found in biological systems and 
materials science. In this example, the most Xe-accessible spore sample (strain 
AD142) was detected at a concentration of just 105 cfu/mL, which is ~7 orders of 
magnitude more sensitive than previous efforts at spore detection using NMR 
spectroscopy.148,149 Moreover, this result did not require specialized sample 
preparation and was achieved without spore destruction, thereby allowing 
downstream analysis of the sample.  
The finding that Hyper-CEST contrast increased in spores where outer 
structures were absent strongly suggests that Xe in aqueous solution gains ready 
access to the spore interior, where the rate of the exchange process depends on the 
thickness and/or composition of the outer layers present. The finding that the 
exosporium effectively limits Xe entry into the spore is notable and is consistent 
with the view that the exosporium acts as a molecular sieve. Specifically, the hairy 
nap on the exosporium outer surface provided a remarkably effective barrier to 
xenon entry. Taken as a whole, our results show that Hyper-CEST NMR provides a 
novel method for noninvasive spore detection and a powerful tool for probing the 
physical and chemical properties of the spore interior. Hyper-CEST is an especially 
powerful method to distinguish between spores that are morphologically similar but 
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differ in characteristics that mediate Xe exchange. We conclude that, in combination 
with genetic manipulation of spore ultrastructure, Hyper-CEST NMR can generate 
new insights into spore composition and function that have previously been difficult 
or impossible to analyze.  
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Figure 4.1: 129Xe Hyper-CEST experiment with spores. (A) B. anthracis strains: A, Sterne 
34F2 (wild type), B, Sterne-JAB-13 (bclA), C, RG56 (cotE). (B) B. subtilis strains: D, 
PY79 (wild type), E, AD28 (cotE), F, AD142 (cotE gerE). While some coat likely remains 
in AD142 spores,142 we have not indicated this in the figure, for simplicity. (C) Scheme 
showing Hyper-CEST NMR experiment with spores. 
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Figure 4.2: Hyper-CEST NMR profile and depolarization curve of wild-type B. anthracis 
spores at 1.2 × 109 cfu/mL. (A) NMR profile acquired at 0.5 ppm resolution, at 278 K, with 
600 pulse cycles for saturation exchange (11.6 s saturation time). Two peaks (196.2 ppm 
and 193.4 ppm) are shown for the spores and water, respectively. (B) Saturation 
frequencies for depolarization curve were 197.5 = (193.2 + 4.5) ppm and 188.9 = (193.2 - 
4.5) ppm, for ‘on’ and ‘off’ resonance, respectively.  
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Figure 4.3: Comparison of saturation transfer (ST) efficiencies across six spore strains 
measured at 1.2×107 cfu/mL. 
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Table 4.1: Saturation transfer (ST) efficiency and exchange signal NMR chemical shift for 
six spore strains. 
 
  
Spore Strain ST Efficiency 
129Xe(spore) NMR 
chemical shift (ppm) 
B. anthracis 
Sterne 34F2  196  8 
Sterne JAB-13 0.12  199  
RG56 0.14  198  
B. subtilis 
PY79 0.11  198  
AD28 0.21  199  
AD142 0.42  197  
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CHAPTER 5 CUCURBIT[6]URIL IS AN ULTRASENSITIVE 129XE NMR 
CONTRAST AGENT 
Reproduced by permission of The Royal Society of Chemistry, Yanfei Wang and Ivan J. 
Dmochowski, Chem. Commun., 2015, 51, 8982, DOI:10.1039/C5CC01826A.51 
 
5.1 Introduction  
Xenon is very soluble in organic solvents and accumulates in vivo in lipid 
environments, while exhibiting low affinity for endogenous proteins and other 
biomolecules. Cryptophane-A and its derivatives are the most studied Xe-binding 
cages, and water-soluble versions exhibit association constants in excess of 30,000 
M-1 at rt.18,19,24 However, multi-step syntheses yield just milligram quantities of 
water-soluble cryptophane.15 New xenon-binding contrast agents are needed to 
expand applications of hp 129Xe in chemical sensing, biophysical chemistry, and 
biomedical imaging. 
The unique hollow structures and molecular recognition properties of the 
cucurbit[n]uril (CB[n]) family have made CB[n] and functionalized CB[n] useful 
candidates as drug delivery vehicles, components of enzyme assays, and other 
sensing applications.150,151 Commercially available CB[6] (Figure 5.1) possesses 
hexagonal symmetry with a hydrophobic cavity that is accessible through two 
carbonyl-fringed portals of ~4-Å diameter.152,153 CB[6] binds xenon with modest 
affinity but is poorly soluble in pure water. Interestingly, CB[6] becomes water 
soluble in the presence of monovalent cations (as found in biological fluids), 
however cation binding at the portals has been proposed to block xenon binding. 
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Here, we consider whether the CB[6] cavity, which is hydrophobic, rigidly open, 
and of similar dimensions to Xe (diameter ≈ 4.3 Å), can promote rapid Xe exchange 
interactions, as required for detection by hp 129Xe chemical exchange saturation 
transfer. Stevens et al. reported a perfluorocarbon nanoemulsion contrast agent for 
129Xe NMR, with each droplet encapsulating multiple xenon atoms, depending on 
droplet size.49 PFOB nanodroplets were recently applied for multiplexed detection 
using Hyper-CEST NMR in mammalian cells.50 In order to advance many 
applications we have sought new molecular scaffolds for Hyper-CEST NMR. 
Here, the rapid, reversible complexation of xenon by CB[6] was investigated 
in physiologically relevant buffer solution (where CB[6] is soluble to greater than 
10 mM), and exploited for Hyper-CEST NMR experiments in human plasma. 
Through selective saturation and magnetization transfer, the 129Xe-CB[6] peak was 
encoded and amplified in the 129Xe-solution peak (Figure 5.1).  
5.2 Results and discussion 
5.2.1 Detection of CB[6] in buffer  
The hp 129Xe NMR spectrum obtained with 5 mM CB[6] using a direct detection 
method showed that the 129Xe-CB[6] peak in pH 7.2 PBS (1.058 mM potassium 
phosphate monobasic, 154 mM sodium chloride, and 5.6 mM sodium phosphate 
dibasic) was 72 ppm upfield-shifted from the 129Xe-water peak (Figure 5.2). Due to 
rapid exchange of xenon with CB[6], the line shape of both 129Xe NMR peaks 
appeared broad. Nonetheless, the “bound” 129Xe peak was well-separated from the 
“free” peak, allowing it to be selectively irradiated with rf pulses without perturbing 
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free hp 129Xe in solution. Thermodynamic and kinetic parameters associated with 
the complexation of xenon by CB[6] at 300 K in PBS solution were determined by 
2D hp 129Xe NMR exchange spectroscopy (Figure 5.3). 2D-EXSY spectra were 
recorded with 2048 data points in t2 domain and 16 data points in t1 domain, using 
States-TPPI method in the t1 dimension. To evaluate the exchange rate constant, 
equations were used as described previously (Methods section).154 The extracted rate 
constants for association and dissociation, kon and koff, were 4.1*105 M-1s-1 and 840 
s-1, respectively. This result is similar to koff values determined by Kim et al. for a 
more water-soluble CB[6] derivative: koff = 2300 s-1 in water, koff = 310 s-1 in 0.4 M 
Na+ solution.155 We determined the association constant (KA = kon/koff) for xenon and 
CB[6] in PBS at pH 7.2 to be 490 M-1 at 300 K, in accord with previous 
measurements for this Xe-host interaction,155,156 taking into account the intermediate 
buffer salt concentration. The koff value determined by EXSY was similar to the 
measured exchange rate from line-width analysis for the corresponding 129Xe NMR 
spectrum (kexch = 1470 s-1, Figure 5.4). Xe affinity determined for CB[6] in PBS at 
300 K was ~40-fold lower than measured previously for TAAC.18 However, the 
129Xe-CB[6] exchange rate was ~17-fold higher than previously measured for 129Xe-
TAAC (kexch = 86 s-1) at 300 K,52 and should afford efficient magnetization transfer, 
as required for ultrasensitive detection in the Hyper-CEST scheme.  
To test CB[6] for Hyper-CEST NMR spectroscopy, multiple selective Dsnob-
shaped saturation pulses were scanned over the chemical shift range of 85-210 ppm 
in 5-ppm steps. Two saturation responses were observed (Figure 5.5), centered at 
193 ppm (129Xe-aq) and 122 ppm (129Xe-CB[6]). Similar to the direct detection 
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spectrum with 5 mM CB[6] (Figure 5.2), both peaks in the Hyper-CEST z-spectrum 
with 0.8 µM CB[6] appeared broad, which allowed for a broad saturation frequency 
window. 
Ultrasensitive indirect detection of CB[6] was achieved by applying shaped rf 
saturation pulses at the chemical shift of 129Xe in CB[6], and measuring the residual 
aqueous 129Xe signal after spin transfer as on-resonance CEST response (Figure 5.6 
and Figure 5.7). The observed depolarization response in Hyper-CEST experiments 
arose from both self-relaxation of hp 129Xe and CB[6]-mediated saturation transfer. 
The depolarization rates were obtained by fitting both on-resonance and off-
resonance decay curves to first-order exponential kinetics. Remarkably, 1.8 pM 
CB[6] was readily detected in PBS at 300 K. Average of three trials gave τon = 24.6 
± 1.2 s and τoff = 58.5 ± 3.7 s. The high S/N at picomolar concentration is comparable 
to our previous Hyper-CEST measurements with TAAC, which required elevated 
temperature (320 K) to achieve similar 103 s-1 exchange kinetics.52 As postulated 
previously for TAAC,52 CB[6]-mediated exchange is likely enhanced by peripheral 
Xe atoms undergoing rapid magnetization transfer with the “bound” Xe atom at the 
primary site. Indeed, the open, tubular structure of CB[6] may promote 129Xe-CB[6]-
129Xe exchange interactions at both portals. Importantly, xenon is very soluble (4.2 
mM atm-1) in water at 300 K,115 and working near rt is convenient for many 
biochemical and cellular assays.  
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5.2.2 Detection of CB[6] in biological fluids  
Having established CB[6] as an ultrasensitive 129Xe NMR contrast agent in 
physiologic buffer solution, we investigated the feasibility of using this agent in 
biological fluids. We first performed Hyper-CEST NMR experiments with 1 µM 
CB[6] in blood plasma (purchased from Sigma), and observed a peak at the 
characteristic 129Xe-CB[6] chemical shift, 122 ppm (Figure 5.8). As expected, the 
aqueous Xe peak was broader, based on the faster exchange of hp 129Xe in plasma. 
The many components of blood plasma that can interact with CB[6] also contributed 
to the hp 129Xe-CB[6] peak being less intense than observed in PBS. Polyamines, 
for example, are naturally occurring organic molecules found in all living organisms 
and are known to have high affinity for CB[6] relative to other small molecules.157 
Polyamines are present at millimolar concentrations inside living cells, with ~10 
percent being free polyamines, and at micromolar concentrations in biological 
fluids.158,159 Putrescine is believed to be the most abundant polyamine in most 
biological fluids, and is strongly associated with cancer and chemotherapy.160,161 We 
confirmed by isothermal titration calorimetry (ITC) that putrescine has high affinity 
for CB[6] in PBS (KA = 3.6*106 M-1 at 300 K, Figure 5.9). To investigate the effect 
of putrescine on CB[6]-mediated Hyper-CEST signal in this biological fluid, we 
added 10 µM putrescine to the 1 µM CB[6]-plasma solution. The 129Xe-CB[6] 
Hyper-CEST signal at 122 ppm remained visible but was reduced as a result of less 
free CB[6] in the sample (Figure 5.8). These experiments suggest that it is feasible 
to use CB[6] as a sensitive in vivo 129Xe contrast agent in environments where 
competing polyamines exceed CB[6] concentration by less than 10-fold. 
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To quantify how polyamines affect CB[6] Hyper-CEST efficiency, we carried 
out a set of experiments with putrescine in PBS, which has similar salt concentration 
to plasma but affords longer T1 (~60 sec) of hp 129Xe. Putrescine concentrations of 
1 µM to 50 µM were investigated, as this is the relevant range in biological fluids.159 
For each putrescine sample, 1 µM CB[6] was added and incubated for 20 min at 300 
K. Then, the same Hyper-CEST NMR method was used as shown in Figure 5.6, 
with slightly adjusted saturation pulse. Saturation transfer efficiency (ST) which is 
proportional to MR image contrast, and free CB[6] concentration were calculated 
for each putrescine sample (Table 5.1). With increasing putrescine in solution, the 
amount of CB[6] available for Xe exchange decreased, and a correspondingly 
smaller ST contrast value was observed. This experiment further demonstrated that 
only small excess of CB[6] (e.g., 5 nM CB[6] in PBS) is needed to generate useful 
Hyper-CEST contrast at intermediate field strength (B1,max = 92 µT). 
A corollary from this experiment is that CB[6] enables fast and sensitive 
detection of putrescine in solution, without need for polyamine derivatization, by 
correlating the difference between on- and off-resonance hp 129Xe decay rates to 
putrescine concentration. (Figure 5.10 and 5.11) To date, efforts with Hyper-CEST 
have focused on targeting proteins,37 lipids,39 or metal ions162 by attaching different 
recognition moieties to cryptophane. Here, through competing guest encapsulation 
and “turn off” sensing, CB[6] affords new capabilities in small-molecule detection. 
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5.3 Methods 
All phosphate-buffered saline (PBS) used in this work was 1.058 mM potassium phosphate 
monobasic, 154 mM sodium chloride, and 5.6 mM sodium phosphate dibasic, pH 7.2. 
The following organic and biological reagents were purchased from Sigma-Aldrich: 
Cucurbit[6]uril (CB[6]), putrescine (analytical standard), and plasma (from human).  
5.3.1 Hyperpolarized 129Xe NMR spectroscopy 
After Xe collection, 5 mm NMR tubes were shaken vigorously to mix solutions with Xe. 
Direct hp 129Xe NMR measurements were performed on a Bruker BioDRX 500 MHz NMR 
spectrometer (138.12 MHz frequency for 129Xe), using a 5-mm BBO NMR probe. Sample 
temperature was controlled by VT unit on NMR spectrometer to 300 ± 1 K. Spectrum was 
collected 30-60 seconds after sample insertion. Chemical shifts were referenced relative to 
129Xe gas at 0 ppm when extrapolated to 0 atm. 
5.3.2 Hyper-CEST experiments 
All Hyper-CEST experiments were carried out using a Bruker 500 MHz NMR 
spectrometer, with 10-mm PABBO probe. A 90° hard pulse of this probe has pulse length 
of 22 µs.  
A. For Hyper-CEST frequency-scan profile (Figure 5.5 and Figure 5.8), saturation 
pulse Dsnob with 690 Hz bandwidth was used. Pulse length tpulse = 3.80 ms, field 
strength B1,max = 77 µT, number of pulses npulse= 400, saturation time tsat = 1.52 s. 
B. For saturation time curves (Figure 5.6 and Figure 5.7), saturation pulse Dsnob with 
2500 Hz bandwidth was used. Pulse length tpulse = 1.05 ms, field strength B1,max = 
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279 µT, number of pulses linearly increased from 0 to 6000, saturation time tsat 
correspondingly increased from 0 to 6.3 sec. Figures were fitted with mono-
exponential decay function y = exp (-x/τ). 
C. For Table 5.1 and Figure 5.10, saturation pulse Dsnob with 833 Hz bandwidth was 
used. Pulse length tpulse = 3.15 ms, field strength B1,max = 92 µT, number of pulses 
linearly increased from 0 to 2000, saturation time tsat correspondingly increased 
from 0 to 6.3 sec. The calculation of ST efficiency was based on the equation 4.1. 
5.3.3 Hyperpolarized 129Xe exchange spectroscopy 
HP gas was directly bubbled into the 3-mL sample solution through capillaries for 20 sec 
(flow rate 0.7 L per min), followed by a 2-sec delay to allow bubbles to collapse. 
Subsequently three successive 90 degree pulses were applied. The above process was 
repeated for each point in the t1 domain. And the following equations were used to evaluate 
rate constants.  
ܣ ൌ expሺെܴ߬௠ሻ , ሺ1ሻ																		ܣ ൌ ฬܫଵଵ/ܯଵ ܫଵଶ/ܯଶܫଶଵ/ܯଵ ܫଶଶ/ܯଶฬ                                                
ܴ ൌ ି௑	ሺ୪୬஽ሻ௑షభఛ೘ , ܴ ൌ ฬ
െܴଵ െ ݇ଵᇱ ݇ିଵᇱ
݇ଵᇱ െܴଶ െ ݇ିଵᇱ ฬ                                                        (5.1) 
A is a matrix which contains the peak amplitudes measured at a certain mixing time τ୫ 
divided by the intensities of the diagonal peaks in the reference spectrum (0 mixing time). 
Matrix R is the solution to equation 1, according to eigenvector method, and it contains 
the kinetic parameters to be determined, ݇ଵᇱ 	and	݇ିଵᇱ  (kon and koff).  
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5.3.4 Hyper-CEST efficiency for different concentrations of putrescine 
By fitting Hyper-CEST signal to an exponential decay function (Figure 5.10), we 
extracted the decay constants for both on-resonance (122.3 ppm = 193.5 – 71.2 
ppm)) and off-resonance (264.7 ppm = 193.5 + 71.2 ppm) for each sample. Using 
the first-order kinetics approximation, the difference of on- and off-resonance 
relaxation rate was hypothesized to be a linear function of the concentration of 
available exchange sites (i.e., free CB[6]). Such fitting provided an empirical 
estimation of parameter p in Equation 4, in which other coefficients and constants 
including relaxation rate, exchange kinetics and field strength were incorporated. 
ܭ஺ ൌ ௖಴ಳሾలሿ್೚ೠ೙೏൫௖೛ೠ೟ೝି௖಴ಳሾలሿ್೚ೠ೙೏൯∗ሺ௖಴ಳሾలሿ	ି	௖಴ಳሾలሿ್೚ೠ೙೏ሻ                                                 (5.2) 
Equation (5.2) is equivalent to  
ܭ஺ ൌ ௖಴ಳሾలሿ	ି	௖಴ಳሾలሿ೑ೝ೐೐൫௖೛ೠ೟ೝା	௖಴ಳሾలሿ೑ೝ೐೐ି	௖಴ಳሾలሿ൯∗		௖಴ಳሾలሿ೑ೝ೐೐                                                             (5.3) 
where cCB[6]bound is the putrescine-bound CB[6] concentration, cCB[6]free is the free CB[6] 
concentration, cCB[6] is the total CB[6] concentration and cputr is the putrescine 
concentration. Using the first-order kinetics approximation, the difference of on- and off-
resonance relaxation rate (λon - λoff) was hypothesized to be a linear function of the 
concentration of available CB[6] exchange sites (ܿ஼஻ሾ଺ሿ௙௥௘௘).  
Hence, we have  
ܿ஼஻ሾ଺ሿ௙௥௘௘ ൌ ݌ ∗ ߣௗ௜௙௙ ൌ ݌ ∗ ሺ	ߣ௢௡ െ	ߣ௢௙௙ሻ                                                         (5.4) 
where p incorporates other coefficients and constants including spin-spin relaxation rate 
and field strength.  
ܿ௣௨௧௥ ൌ ௖಴ಳሾలሿି௣∗ఒ೏೔೑೑௄ಲ∗௣∗ఒ೏೔೑೑ ൅ ܿ஼஻ሾ଺ሿ െ ݌ ∗ ߣௗ௜௙௙                                                                   (5.5)	
71 
where cCB[6] is the concentration of CB[6] (1 µM), KA is the association constant for 
putrescine binding to CB[6], λdiff is the difference of on- and off-resonance decay rate 
derived from Hyper-CEST experiment, cputr is the putrescine concentration. Data fitting 
(Figure 5.11) the experimentally determined λdiff values for the biologically relevant range 
of putrescine concentrations gave a p value that was in good agreement with the 
theoretically predicted p value. Equation 5.5 is used for curve fitting in Figure 5.11.  
As Zaiss et al. discussed,76 
ߣௗ௜௙௙ ൌ 	 ௞ೌଵା௞್∗ሺ௞್ାோమ್ሻ/௪భమ ,			ݓ݄݁ݎ݁	݇௔ ൌ 	
ெ್
ெೌ ∗ ݇௕                                             (5.6) 
As w1 >> kb2+ kb* R2b in these experiments, the above could be simplified as,  
ߣௗ௜௙௙ ൌ 	ெ್ெೌ ∗ ݇௕ ൌ 	݇௕ ∗ 	ܭ஺ ∗ ܿ஼஻ሾ଺ሿ௙௥௘௘ ൌ ݇௕ ∗ 	ܭ஺ ∗ ݌ ∗ ߣௗ௜௙௙                             (5.7) 
From above p is estimated to be 1/ (840 s-1 * 490 M-1) = 2.4*10-6  M*s, which is similar 
to the fitted value (Figure 5.11). 
5.4 Conclusions and future directions 
We demonstrated that commercially available cucurbit[6]uril can serve as a Hyper-
CEST 129Xe NMR contrast agent, both in physiologic buffer solution and a model 
biological fluid (human plasma). 2D-EXSY experiments confirmed that xenon kexch 
with CB[6] is rapid but does not approach the fast exchange limit on the 129Xe NMR 
time scale, which allowed the use of broadband irradiation to achieve efficient 
saturation of the 129Xe-CB[6] complex without affecting free hp 129Xe in solution. 
Efficient saturation transfer enabled low picomolar detection of CB[6] at 300 K, 
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which was equivalent to the previous single-site Hyper-CEST detection record 
achieved in our laboratory using water-soluble cryptophane TAAC at 320 K.52 Our 
data suggest that for many applications in aqueous buffer solution near rt, CB[6] 
should provide superior Hyper-CEST signal to water-soluble cryptophanes. A 
variety of cucurbituril derivatives163 and acyclic variants164,165 have been reported 
that highlight opportunities for cucurbituril functionalization, as will likely be 
required to target specific biomolecules in solution.  
CB[6] is very soluble in biological fluids and may also prove useful as a 
MRI/MRS contrast agent for in vivo applications. This will depend on the circulation 
time and localization of CB[6] in vivo, among other factors. One potential limitation 
of using CB[6] as a 129Xe MR contrast agent is the competition for available xenon 
binding sites from endogenous small molecules. Importantly, saturation transfer 
efficiency was found to be strongly correlated with free CB[6] concentration, which 
is useful for establishing conditions that are amenable to the Hyper-CEST approach, 
even when the nature of the competing species is not perfectly known. For example, 
we showed that Hyper-CEST contrast can be achieved for CB[6] in plasma, which 
contains many competing species including high-affinity polyamines. Finally, we 
determined that it is possible to exploit the promiscuity of CB[6] to estimate the 
concentration of a known small molecule (e.g., putrescine) that competes with xenon 
for the binding cavity. The ready availability and versatile host-guest chemistry of 
CB[6] opens many in vitro as well as in vivo applications, employing direct detection 
of hp 129Xe or Hyper-CEST NMR. Following our work with cryptophanes, we aim 
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to develop cucurbituril xenon biosensors that take advantage of the special Hyper-
CEST capabilities of this contrast agent. 
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Figure 5.1: Top: Chemical structures of CB[6] and TAAC. Bottom: Hyper-CEST 
mechanism involving xenon-binding molecules represented by hexagons. 
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Figure 5.2: Hyperpolarized 129Xe NMR spectrum with 5 mM CB[6] dissolved in pH 7.2 
PBS at 300 K. A 30 degree pulse was used and signal averaged over 8 scans. Fourier-
transformed spectra were processed with zero-filling and Lorentzian line-broadening of 20 
Hz. Peak width (FWHM) was 463 Hz for 129Xe-aq peak, and 570 Hz for 129Xe-CB[6] peak. 
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Figure 5.3: 2D hp 129Xe EXSY spectra in the presence of 5 mM CB[6] in PBS with 0 s 
mixing time (control, top) or 2 ms mixing time (bottom). 
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Figure 5.4: Hyperpolarized 129Xe NMR spectrum of 0.5 mM cucurbit[6]uril in PBS, pH 
7.2, 300 K. Eburp2-shaped pulses (2000 Hz width) were used to selectively excite 
Xe@CB[6] peak. A delay of 0.5 s was given between scans to allow for Xe exchange 
from solution into CB[6]. Spectra were averaged over 4 scans. Fourier-transformed 
spectra were processed with zero filling and Lorentzian line-broadening of 50 Hz. The 
Xe-CB[6] peak width (FWHM) is 470 Hz (magnetic homogeneity corrected), which 
corresponds to koff of 1470 s-1. 
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Figure 5.5: Hyper-CEST frequency-scan profile of 0.8 µM CB[6] in pH 7.2 PBS at 300 K. 
When saturation rf pulse was positioned at 121 ppm (-72 ppm from 129Xe-aq peak), 
encapsulated 129Xe was depolarized and exchange caused rapid decrease in 129Xe-aq signal. 
The black squares show the experimental data, and the lines show the exponential 
Lorentzian fits.76 
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Figure 5.6: Representative Hyper-CEST profile of 1.8 pM CB[6] in pH 7.2 PBS at 300 K. 
Saturation frequencies of Dsnob-shaped pulses were positioned at 122.3 ppm (193.5 – 71.2 
ppm) and 264.7 ppm (193.5 + 71.2 ppm), for on- and off-resonance. Pulse length, τpulse = 
1.05 ms; field strength, B1,max = 279 µT. 
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Figure 5.7: An example of Hyper-CEST profile of 18 pM CB[6] in pH 7.2 PBS at 300 K. 
Saturation frequencies of Dsnob-shaped pulses were positioned at 122.3 = (193.5 – 71.2) 
ppm and 264.7 = (193.5 + 71.2) ppm, for on- and off-resonance. 
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Figure 5.8: Hyper-CEST spectra shown for 1 µM CB[6] in PBS (black), in blood plasma 
(blue), and in blood plasma with 10 µM putrescine (red); all data collected at 300 K.  
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Figure 5.9: ITC measurements performed with CB[6] at 300 K. 200 µM putrescine was 
titrated into 20 µM CB[6].  
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Putrescine (µM) Calculated free CB[6] concentration (µM) ST efficiency 
0 1.0  
1 0.41 0.67  
2 0.19 0.34  
5 0.064 0.25  
10 0.030 0.16  
20 0.014 0.10  
50 0.0056 0.08  
 
Table 5.1: Saturation transfer (ST) efficiency for 1 µM CB[6] samples in PBS with varying 
putrescine concentration. 
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Figure 5.10: Hyper-CEST profiles of 7 different samples in pH 7.2 PBS buffer at 300 K. 
Saturation frequencies of Dsnob-shaped pulses were positioned at 122.3 = (193.5 – 71.2) 
ppm and 264.7 = (193.5 + 71.2) ppm, for on- and off-resonance. Data were fit with 
mono-exponential decay function y = exp (-x/t1).  
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  Table 5.2: Fitting statistics for Figure 5.10. 
   t1 is the exponential decay time constant, k = 1/t1 is the decay rate, tau = t1 * ln 2 is the mean lifetime. 
 y0 A1 t1 t1 k k tau Statistics Statistics 
 Value Value Value Standard 
Error 
Value std err Value Reduced 
Chi-Sqr 
Adj. R-
Square 
 1 µM CB[6] on 0 1 3.37176 0.07358 0.29658 0.006472 2.33712 2.94E-04 0.99664 
 1 µM CB[6] off 0 1 53.24035 4.60424 0.01878 0.001624 36.9034 2.19E-04 0.83776 
 1 µM CB[6] +1 µM 
putrescine on 
0 1 3.20652 0.02856 0.31186 0.002777 2.22259 4.83E-05 0.99951 
 1 µM CB[6] +1 µM 
putrescine off 
0 1 35.04003 3.59041 0.02854 0.002920 24.2879 6.43E-04 0.73133 
 1 µM CB[6] +2 µM 
putrescine on 
0 1 8.11589 0.17207 0.12322 0.002612 5.62551 2.07E-04 0.99434 
 1 µM CB[6] +2 µM 
putrescine off 
0 1 34.44633 4.46034 0.02903 0.003758 23.87638 1.06E-03 0.68633 
 1 µM CB[6] +5 µM 
putrescine on 
0 1 11.36809 0.31507 0.08797 0.002438 7.87976 2.50E-04 0.98809 
 1 µM CB[6] +5 µM 
putrescine off 
0 1 43.28092 4.92099 0.0231 0.002626 30.00005 5.48E-04 0.65595 
 1 µM CB[6] +10 
µM putrescine on 
0 1 17.78367 0.56703 0.05623 0.001792 12.3267 1.84E-04 0.9829 
 1 µM CB[6] +10 
µM putrescine off 
0 1 34.91285 3.03295 0.02864 0.002488 24.19974 4.65E-04 0.83062 
 1 µM CB[6] +20 
µM putrescine on 
0 1 21.69607 1.33518 0.04609 0.002836 15.03857 5.09E-04 0.91999 
 1 µM CB[6] +20 
µM putrescine off 
0 1 46.04456 5.174 0.02172 0.002440 31.91566 4.80E-04 0.65711 
 1 µM CB[6] +50 
µM putrescine on 
0 1 27.10952 1.87783 0.02689 0.002555 18.79089 4.52E-04 0.88971 
 1 µM CB[6] +50 
µM putrescine off 
0 1 60.95673 4.11003 0.01641 0.001106 42.25199 1.04E-04 0.92448 
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Figure 5.11: Decay rate difference plotted as a function of putrescine concentration. 
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CHAPTER 6 PROGRAMMING A MOLECULAR RELAY FOR 
ULTRASENSITIVE BIODETECTION VIA HYPERPOLARIZED 129XE NMR 
SPECTROSCOPY 
Reproduced by permission of Angewandte Chemie International Edition, Yanfei Wang, 
Benjamin W. Roose, John P. Philbin, Jordan L.Doman, Ivan J. Dmochowski, 
Angew.Chem. Int.Ed. 2016, 55,1733 –1736, DOI: 10.1002/anie.201508990.53 Copyright 
(2015) John Wiley and Sons. 
6.1 Introduction 
Methods for controlling the sequential interaction of molecules in solution can yield new 
functionality and complexity, as evidenced by many enzyme- and small-molecule-
mediated tandem reactions, drug delivery strategies, and nanoscale and mesoscale 
architectures and working ‘machines’.166-168 Less investigated are supramolecular 
strategies for improving in situ sample analysis, e.g., for generating high contrast in bio-
assays and molecular imaging. Our lab and Schröder’s recently showed that commercially 
available cucurbit[6]uril provides exceptional contrast at pM concentration via 
hyperpolarized 129Xe chemical exchange saturation transfer.169,170 CB[6] is not readily 
functionalized for biosensing applications. Thus, we exploited the versatile host-guest 
chemistry of CB[6] to develop a de novo “molecular relay” that reports on specific proteins 
in solution.  
129Xe NMR/MRI has enabled investigations of many complex porous systems, from 
inorganic and organic materials171,172 to bacterial spores48 and mammalian lungs.173 For 
detection of specific proteins in solution, however, a specific encapsulating agent is 
required as Xe has low affinity for endogenous biomolecules. Cryptophane-A and its 
derivatives are the most studied Xe-binding cages and these exhibit the largest association 
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constants.22,174 However, cryptophane biosensors require multi-step synthesis that yields 
only milligram quantities. This has motivated the search for new 129Xe-binding 
scaffolds.49,57,175 
The rigid structure and unique molecular recognition properties of cucurbit[n]uril 
(CB[n]) compounds make these useful as drug delivery vehicles, chemical reaction 
chambers, and components of enzyme assays.150,176-179 CB[n] have also been reported as 
building blocks in stimuli-responsive supramolecular architectures, for fluorescence 
enhancement, and in self-sorting systems in supra-biomolecular assembly that can regulate 
enzyme activity.180-182 Importantly, CB[6] has a suitable cavity size to bind Xe (D ≈ 4.3 Å), 
and CB[6] and a water-soluble derivative were reported to bind Xe with useful affinities 
(KA = 500-3000 M-1 at rt).183,169 Here, we describe CB[6]-129Xe NMR biosensors 
programmed for three sequential recognition events (Figure 6.1): a two-faced guest (TFG) 
initially binds CB[6], TFG is sequestered by cognate protein thereby freeing CB[6], and, 
lastly, xenon binds CB[6] for ultrasensitive detection by Hyper-CEST NMR. The TFG is 
engineered to control this relay, such that CB[6]-129Xe NMR signal is absent until addition 
of analyte.  
6.2 Results and discussion 
CB[6]-guest binding affinities first measured by Mock and co-workers184 guided our design 
of TFGs that bind CB[6] with intermediate affinity (displacing Xe), and are readily 
sequestered upon binding the opposite TFG face to a higher-affinity protein target. 
Butylamine was measured by ITC to exhibit intermediate affinity for CB[6], KA = 2.85 x 
105 M-1 in pH 7.2, PBS solution at 300 K (Figure 6.2). We chose human carbonic anhydrase 
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II (CAII, EC 4.2.1.1) as the initial target protein, as this is a model single-site enzyme with 
biomedical significance185 and its inhibitors have been well studied.186 The active site of 
CAII resides at the base of a ~15-Å deep conical pocket that can differentiate between 
TFGs even if they share the same Zn2+-targeting functional group, as previously 
demonstrated for many CA inhibitors.187 We therefore designed TFGs 1-4 (Table 6.1) with 
a CAII-binding p-benzenesulfonamide moiety and CB[6]-binding butylamine tail, while 
varying the length and chemical structure of the linker. 
Synthetic details for TFGs 1-4 are provided in the Methods section. Briefly, 
following procedures modified from Salvatore et al.,188 1 and 2 were synthesized from the 
primary amine and alkyl bromide in a single step using cesium hydroxide monohydrate as 
the base in 30% and 43% yield. TFGs 3 and 4 were synthesized in two steps. In the first 
step, 2-chloroacetyl chloride was reacted with 4-(2-aminoethyl)benzenesulfonamide or 4-
aminobezenesulfonamide in 68% or 70% yield and subsequently reacted with 1-
butylamine to deliver 3 or 4 in 56% or 50% yield. 
To test whether the TFGs function as desired in the prototypal CB[6] molecular relay, 
binding affinities were measured by ITC separately for CB[6] and CAII (Table 6.1, Figure 
6.2). The association constants for CB[6] titrated with 1, 2, 3, or 4 were all in the range of 
1-3 x 105 M-1 at 300 K in pH 7.2, PBS buffer with 1% DMSO. We then performed ITC to 
test binding of 1-4 to CAII in the same buffer, and 4 displayed the highest affinity. 
Interestingly, titration of 1 into CAII solution was endothermic. The likely origins of the 
enthalpic and entropic contributions towards 1 binding to CAII are observed in the crystal 
structure of the enzyme-TFG complex (Figure 6.3). The benzenesulfonamide moiety of 1 
forms the interactions typically observed for arylsulfonamide inhibitors: the sulfonamidate 
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(N) coordinates to the catalytic Zn2+ and donates a hydrogen bond to the hydroxyl oxygen 
of T199, and a sulfonamide oxygen accepts a hydrogen bond from the backbone amide 
nitrogen of T199. The n-butyl tail of 1 occupies a hydrophobic pocket lined by residues 
L198, P202, L204, F131, V135, and L141. Other sulfonamide inhibitors with flexible, 
hydrophobic tails have also been observed to occupy this pocket.189,190 The amine nitrogen 
in the tail of 1 is positioned near residues L198 and P202 but does not form hydrogen bonds 
with the protein or solvent. This limits enthalpic contributions to TFG binding, whereas 
solvent displacement contributes significant entropy to ΔG. 
A crystal structure of CAII bound to the longest TFG 3 (Figure 6.4) shows that the 
amine nitrogen is only 4.8, 5.1 and 5.4 Å from three neighboring residues, respectively. 
Based on these distances, TFG 3 is not available to bind simultaneously to CB[6], with 
outer diameter of 6.9 Å at its portal and 14.4 Å at its widest point.191,192 Molecular modeling 
(Figure 6.5) helps to illustrate that a stable ternary structure cannot form between CAII, 
TFG 3 and CB[6] due to steric clashes. Finally, a crystal structure of CAII with TFG 4 
(lacking an ethyl linker), confirms that the butyl tail is even less solvent accessible in this 
complex (Figure 6.6). 
The CB[6]-TFG complexes were incubated with CAII for 20 min, and the hydrolysis 
rates of p-nitrophenyl acetate (pNPA) enzymatically catalyzed by CAII were determined 
by monitoring an increase in absorbance at 400 nm (Figure 6.7). Compounds 3 and 4 
displayed stronger CAII inhibition compared to the other TFGs, which is consistent with 
their higher CAII affinity. CB[6] alone did not show any CAII inhibition, which suggested 
lack of direct interaction between CAII and CB[6]. All TFGs when complexed with CB[6] 
inhibited CAII activity only slightly less than TFG alone, which provides further evidence 
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that the TFGs shuttle from CB[6] to CAII, as designed. Furthermore, higher concentrations 
of CB[6] led to greater recovery of CAII activity (Figure 6.8), proving that the shuttling of 
TFG is under thermodynamic control.  
Based on its highest affinity for CAII and intermediate affinity with CB[6] (Table 
6.1), TFG 4 was selected for testing our “turn-on” 129Xe NMR biosensing strategy. First, 1 
µM CB[6] was dissolved in pH 7.2 PBS solution, and multiple selective Dsnob-shaped 
saturation pulses were scanned over the chemical shift range of 90-230 ppm in 5-ppm steps. 
Two saturation responses were observed (Figure 6.9), centered at 193 ppm (129Xe-aq) and 
122 ppm (129Xe-CB[6]). Upon addition of 4 µM TFG 4, the 129Xe-CB[6] Hyper-CEST 
signal at 122 ppm was greatly reduced as a result of less free CB[6] (~ 0.5 µM) in the 
sample solution. Finally, when 4 µM CAII was added to the solution, 129Xe-CB[6] Hyper-
CEST signal was mostly restored, confirming that TFG 4 was sequestered by CAII.  
We surmise that the described shuttling of TFG 4 is under thermodynamic control, 
as butylamine undergoes fast exchange (τexch < 10 ms) with CB[6].193 To apply the 
molecular relay to a system with different thermodynamic properties, we employed a 
commercially available pentylamine-biotin (pAB) TFG that binds CB[6] much less tightly 
than its target protein avidin. TFG 5 was determined by ITC (Table 1) to bind to CB[6] 
with modest affinity, KA = 4240 M-1, whereas its affinity for avidin was estimated to be 
much higher, KA ≈ 1014 M-1.194 In order to block xenon access initially, we added 50 µM 
TFG 5 to 1 µM CB[6] solution, and as expected, the 129Xe-CB[6] Hyper-CEST signal was 
completely turned off. Subsequently, administration of 50 µM avidin fully recovered 
129Xe-CB[6] signal (Figure 6.10). These data highlight the ease of reprogramming the 
CB[6]-TFG relay for assaying a wide range of biomolecules in solution.  
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Finally, we investigated the possibility of using our molecular relay in cellular 
environments. BL21(DE3) E. coli expressing recombinant CAII was cultured in LB 
medium and induced with 1 mM IPTG and 1 mM ZnCl2. Cells were then pelleted, washed, 
resuspended in PBS buffer, and lysed with two freeze-thaw cycles. Quantitative SDS gel 
indicated expression level of 12 nmol CAII (3 mL of 4 µM sample solution) from cell 
lysate equivalent to OD600nm = 2 (Figure 6.11). Non-transformed E. coli were grown and 
lysed in the same manner to serve as a negative control. Screening experiments revealed 
that 16 µM CB[6] gave useful residual 129Xe Hyper-CEST NMR signal, despite CB[6] 
binding to many components of the bacterial lysate. Addition of 4 µM TFG 4 to control 
sample with 16 µM CB[6] greatly reduced the Hyper-CEST signal, whereas in lysate from 
CAII-overexpressing E. coli, the original NMR signal intensity was observed (Figure 6.12). 
These experiments highlight the ability of the CB[6] detection scheme to identify a specific 
protein target within a complex mixture. Moreover, we showed previously that Hyper-
CEST NMR parameters can be varied to allow detection of 2 pM CB[6] in buffer solution 
and ~1 µM CB[6] in human plasma.169 Thus, the molecular relay extends the utility of 
CB[6] for ultrasensitive 129Xe NMR biosensing. 
6.3 Methods 
6.3.1 Instrumentation 
1H NMR and 13C NMR spectra were obtained on a 500 MHz Bruker BioDRX NMR 
spectrometer at the University of Pennsylvania NMR facility and were recorded at room 
temperature in deuterated acetonitrile (CD3CN) or methanol (CD3OD). Column 
chromatography was performed using silica gel (60 Å pore size, 40-75 μm particle size) 
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from Sorbent Technologies. High-resolution mass spectrometry (HRMS) data were 
obtained using electrospray ionization (ESI) mass spectrometry on a Micromass Autospec 
at the Mass Spectrometry Center in the Chemistry Department at the University of 
Pennsylvania. Standard workup procedures involved multiple (~3) extractions with the 
indicated organic solvent, followed by washing of the combined organic extracts with 
water or brine, drying over sodium sulfate and removal of solvents in vacuo. All yields are 
reported after purification. ITC experiments were performed with GE Healthcare 
MicroCalTM iTC200 system. hp 129Xe was generated using spin-exchange optical pumping 
(SEOP) method with a home-built 129Xe hyperpolarizer, based on the commercial model 
IGI.Xe.2000 by GE. A gas mixture of 10% nitrogen, 89% helium, and 1% natural 
abundance xenon (Linde Group, NJ) was used as the hyperpolarizer input. 795 nm 
circularly polarized diode laser (OptiGrate SEOP Laser, 30 to 70 W) was used for optical 
pumping of Rb vapor. hp 129Xe NMR measurements were performed on a Bruker BioDRX 
500 MHz NMR spectrometer (138.12 MHz frequency for 129Xe), using a 10-mm BBO 
NMR probe. Sample temperature was controlled by VT unit on NMR spectrometer to 300 
± 1 K. Chemical shifts were referenced relative to 129Xe gas at 0 ppm when extrapolated to 
0 atm. 
6.3.2 Materials  
All phosphate-buffered saline (PBS) used in this work was 1.058 mM potassium phosphate 
monobasic, 154 mM sodium chloride, and 5.6 mM sodium phosphate dibasic, pH 7.2. 
Avidin (10 mg, lyophilized) was purchased from Thermo Fisher Pierce. Organic reagents 
and solvents were used as purchased from the following commercial sources: Sigma-
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Aldrich: 1-butylamine (99.5%), triethylamine (99.5%), cesium hydroxide monohydrate 
(CsOH·H2O, 95+%), 1-bromobutane (99%), 4-aminomethylbenzenesulfonamide (95%), 
4-(2-aminoethyl)-benzenesulfonamide (99%); Fisher: pentylamine-biotin, hydrochloric 
acid, sodium sulfate (anhydrous), sodium chloride, sea sand (washed), potassium carbonate 
(K2CO3, anhydrous), ethyl acetate (EtOAc, HPLC grade), dichloromethane (CH2Cl2, 
HPLC grade), methanol (MeOH, HPLC grade), 1-butanol, 4 Å molecular sieves (Type 4A, 
8-12 mesh beads); Acros Organics: N,N-dimethylformamide (DMF, anhydrous), 
acetonitrile (CH3CN, anhydrous), deuterium oxide (D2O), acetonitrile-d3 (CD3CN); Strem 
Chemicals: cucurbit[6]uril monohydrate (CB[6], 99+%); Alfa Aesar: p-nitrophenyl acetate 
(98+%). 
6.3.3 Hyper-CEST experiments 
 Xe (all isotopes) concentration in Hyper-CEST experiments was ~136 µM = 4 mM/atm * 
3.4 atm * 0.01 (Xe percentage in gas mixture). All Hyper-CEST experiments were carried 
out using a Bruker 500 MHz NMR spectrometer, with 10-mm PABBO probe. A 90° hard 
pulse of this probe has pulse length of 22 µs. For Hyper-CEST frequency-scan profile 
(Figures 3 and 4), Dsnob saturation pulse with 690 Hz bandwidth was used. Pulse length 
tpulse = 3.80 ms, field strength B1,max = 77 µT, number of pulses npulse= 400, saturation time 
tsat = 1.52 s. For Figure 5, Dsnob saturation pulse with 276 Hz bandwidth was used. Pulse 
length tpulse = 9.50 ms, field strength B1,max = 30.8 µT, number of pulses npulse= 400, 
saturation time tsat = 3.80 s. 
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6.3.4 Synthesis of 1, 2 195 
 4-[(butylamino)methyl]-benzenesulfonamide (1) and 4-[2-(butylamino)ethyl] 
benzenesulfonamide (2) were synthesized in one step with yields of 30% and 43%. (Figure 
6.13) Taking 2 as an example, in an oven-dried flask with a suspension containing 4 Å 
molecular sieves (500 mg) and anhydrous DMF (8.3 mL), cesium hydroxide monohydrate 
(285.5 mg, 1.7 mmol, 1 equiv) was added. The mixture was stirred vigorously for 10 min. 
Then, 4-(2-aminoethyl)benzenesulfonamide (340.4 mg, 1.7 mmol, 1 equiv) was added to 
the flask and the reaction mixture was stirred vigorously for 30 min. 1-bromobutane 
(0.1826 mL, 1.7 mmol, 1 equiv) was added to the white suspension and the reaction 
proceeded for 20 h at rt. Then the reaction mixture was filtered and washed several times 
with ethyl acetate. The filtrate was concentrated and taken up in 1 M NaOH. Ethyl acetate 
(5 x 20 mL) was used to extract the product and standard workup procedures followed. The 
crude mixture was purified by column chromatography using a gradient of ethyl acetate to 
5% methanol in ethyl acetate (v/v). The purified 4-[2-
(butylamino)ethyl]benzenesulfonamide (2) was a white powder. 
 1H NMR δ(ppm) for 1 (500 MHz, methanol-d4) 7.90 (d, J = 8.4, 2H), 7.57 (d, J = 
8.4, 2H), 3.99 (s, 2H), 2.75 (t, J = 7.6, 2H), 1.62-1.56 (m, 2H), 1.42-1.34 (m, 2H), 0.95 (t, 
J = 7.7, 3H). 13C NMR (CDCl3) δ(ppm): 144.7, 142.3, 130.6, 127.5, 53.0, 31.4, 24.1, 21.3, 
14.2. HRMS (m/z): [M+H]+ calcd. for C11H18N2O2S, 243.1167; found, 243.1165. 
 1H NMR δ(ppm) for 2 (500 MHz, methanol-d4) 7.45(d, J = 8.3, 2H), 7.57 (d, J = 
8.3, 2H), 3.15(t, J = 8.0, 2H), 3.04(t, J = 8.0, 2H), 2.92(t, J = 8.0, 2H), 1.67-1.61 (m, 2H), 
1.45-1.38(m, 2H), 0.97 (t, J = 7.4, 3H). 13C NMR (CDCl3) δ(ppm): 143.8, 143.4, 130.4, 
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127.7, 50.0, 33.9, 30.1, 24.2, 21.0, 14.0. HRMS (m/z): [M+H]+ calcd. for C12H20N2O2S, 
257.1324; found, 257.1321. 
6.3.5 Synthesis of 3, 4 
2-(butylamino)-N-(4-sulfamoylphenethyl)acetamide (3) and 2-(butylamino)-N-(4-
sulfamoylphenyl)acetamide (4) were synthesized through two step reactions. (Figure 6.13) 
In the first step196 2-chloro-N-(4-sulfamoylphenyl)acetamide or 2-chloro-N-(4-
sulfamoylphenethyl)acetamide was produced by reacting 4-aminobenzenesulfonamide or 
4-(2-aminoethyl)-benzenesulfonamide with chloroacetyl chloride in ~70% yield. In a 
round bottom flask, 4-(2-aminoethyl)-benzenesulfonamide (1.2 g, 6.02 mmol, 1 equiv) and 
K2CO3 (1.66g, 12.04 mmol, 2 equiv) were dissolved in 30 mL anhydrous THF. Flask was 
allowed to cool for 10 min on ice with stirring under N2 atmosphere. Chloroacetyl chloride 
(0.6 mL, 7.23 mmol, 1.2 equiv) was added dropwise under N2 atmosphere and the mixture 
was stirred for another 30 min. Water (20 mL) was added to the mixture to quench the 
reaction, while stirring was continued for another 5 min. The organic layer was separated 
and the aqueous layer was extracted with EtOAc (100 mL x 3). The combined organic layer 
was washed with brine, dried over anhydrous Na2SO4, concentrated in vacuo and purified 
by recrystallization in hexane : MeOH. 
 In the second step197 2-chloro-N-(4-sulfamoylphenethyl)acetamide (1.01 g, 3.65 
mmol, 0.7 equiv) and butylamine (528 mg, 5.21 mmol, 1 equiv) were dissolved in 
anhydrous THF (35 mL) under N2 with stirring. K2CO3 (2.15 g, 15.6 mmol, 3 equiv) and 
KI (433 mg, 2.61 mmol, 0.5 mmol) were then added to the mixture, and reflux was 
continued for 17 h. The reaction mixture was concentrated in vacuo, extracted with acetone 
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(50 mL x 3), and centrifuged. The supernatant was concentrated and then purified with 
flash chromatography (SiO2, CHCl3/MeOH/NH4OH 100:5:1) as a white solid (640 mg, 
2.04 mmol, 56%).  
 1H NMR δ(ppm) for 3 (500 MHz, methanol-d4) 7.85 (d, J = 8.9, 2H), 7.77 (d, J = 
8.9, 2H), 3.41 (s, 2H), 2.63 (t, J = 7.2, 2H), 1.56-1.50 (m, 2H), 1.44-1.36(m, 2H), 0.95 (t, J 
= 7.3, 3H). 13C NMR (CDCl3) δ(ppm): 174.3, 145.3, 143.2, 130.4, 127.4, 52.8, 41.2, 36.4, 
32.8, 25.4, 21.5, 14.3. HRMS (m/z): [M+H]+ calcd. for C14H23N3O3S, 314.1538; found, 
314.1524. 
 1H NMR δ(ppm) for 4 (500 MHz, Acetonitrile-d3) 7.78 (d, J = 8.4, 2H), 7.40 (d, J 
= 8.4, 2H), 3.49-3.43(m, 2H), 3.06 (s, 2H), 2.87 (t, J = 7.0, 2H), 2.44 (t, J = 7.0, 2H), 1.41-
1.24(m, 4H), 0.89 (t, J = 7.2, 3H). 13C NMR (CDCl3) δ(ppm): 172.5, 143.2, 139.9, 128.3, 
120.5, 53.4, 50.3, 32.8, 21.5, 14.3. HRMS (m/z): [M+H]+ calcd. for C12H19N3O3S, 
286.1225; found, 286.1230. 
6.3.6 Protein expression and purification 
A previously-prepared ampicillin-resistant pCAM plasmid containing the full-length 
human CAII gene (GenBank accession no. AAA51909) was transformed into E. coli 
BL21(DE3) competent cells. Cells were grown in 6 L of LB media supplemented with 100 
μg/mL ampicillin at 250 rpm and 37 C to an optical density of ~0.6 at 600 nm. Protein 
expression was induced by adding 1 mM isopropyl-β-D-thiogalactopyranoside and 1 mM 
ZnSO4 (final concentrations). The cells were incubated overnight at 250 rpm and 18 C. 
The cells were pelleted by centrifugation and frozen at -80 C for long-term storage. 
98 
 The frozen cell pellet was thawed and resuspended in lysis buffer [50 mM sodium 
phosphate (pH 7.4), 0.3 M NaCl]. The cells were lysed by two additional rounds of freezing 
and thawing. The lysate was clarified by centrifugation, and the supernatant was loaded 
onto a 5 mL HisTrap hp nickel immobilized-metal affinity chromatography column (GE 
Healthcare Life Sciences) in 50 mM sodium phosphate (pH 7.4), 0.3 M NaCl. CAII was 
eluted with 50 mM sodium phosphate (pH 7.4), 0.3 M NaCl, 0.5 M imidazole. Fractions 
containing CAII were pooled, concentrated with an Amicon Ultra-15 centrifugal filter 
(MWCO = 10 kDa), and further purified by size exclusion chromatography in 50 mM Tris 
(pH 8.0), 10% glycerol using a HiLoad 26/60 Superdex column (GE Healthcare Life 
Sciences). Fractions containing CAII were pooled and concentrated to 45 mg/mL. Analysis 
by SDS-PAGE indicated that the protein was over 95% pure. CAII concentration was 
determined by measuring absorbance at 280 nm (ε280 = 57 000 M-1 cm-1).  
6.3.7 Crystallization 
CAII crystals were grown by the hanging drop vapor diffusion method. 4.0 μL of protein 
solution [44 mg/mL CAII in 50 mM Tris (pH 8.0), 10% glycerol] was mixed with 4.0 μL 
of precipitant solution [50 mM Tris (pH 7.0), 1.3 M sodium citrate] on a siliconized glass 
cover slide (Hampton Research). The hanging drop was suspended over a 1.0 mL reservoir 
of precipitant solution. The hanging drops remained clear after three weeks of incubation 
at 4 C. To facilitate crystallization, the crystallization tray was moved to a 21 C incubator 
and the hanging drops were microseeded by a seeding tool (Hampton Research) with CAII 
crystals previously grown in the same condition. Thick rectangular crystals appeared over 
the course of several weeks. 
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 CAII crystals were soaked with two-faced guest (TFG) ligands 1, 3, and 4 as 
follows: individual CAII crystals were transferred to a 10.0 μL drop of 50 mM Tris (pH 
7.0), 1.3 M sodium citrate, 2.5% (v/v) DMSO containing 1 mM ligand. The sitting drop 
was equilibrated against a 400 μL reservoir of 50 mM Tris (pH 7.0), 1.3 M sodium citrate. 
CAII crystals were soaked with ligand overnight at 21 C. The crystals were transferred to 
cryoprotectant solution [soak solution supplemented with 30% (v/v) glycerol] and then 
flash-cooled in liquid nitrogen. 
 X-ray diffraction data from single crystals of CAII-1 and CAII-4 were collected at 
beamline 14-1 at the Stanford Synchrotron Radiation Lightsource (SSRL). X-ray 
diffraction data from single crystals of CAII-3 were collected at beamline 24ID-E at the 
Advanced Photon Source (APS). Diffraction data were integrated using iMosflm (version 
7.1.1) and processed using AIMLESS from the CCP4 suite of programs. Each structure 
was solved by molecular replacement and refined in the PHENIX (version 1.9) suite of 
programs. Initial phases for the CAII-1 model were calculated from an isomorphous high-
resolution CAII structure (PDB ID 3KS3) less the solvent and ions, and initial phases for 
CAII-3 and CAII-4 models were calculated from the refined model of CAII-1 less the 
ligand, solvent, and ions.  
 Structure refinement was performed in PHENIX and manual model adjustments 
were made in COOT (version 0.8.1). Atomic coordinates for 1, 3, 4, and glycerol were 
generated using ChemDraw (version 14.0) and Chem3D Pro (version 14.0), and geometric 
restraints were generated using eLBOW. The B-factors of protein atoms, ligand atoms, and 
ions were refined anisotropically whereas the B-factors of solvent molecules were refined 
isotropically. Disordered protein atoms showing no electron density in the 2Fo-Fc map were 
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deleted from the protein model. Refinement proceeded until Rfree converged at its lower 
limit. The quality of the final model was assessed using MolProbity. Data collection and 
refinement statistics for all structure determinations are recorded in Table 6.2. Figures were 
generated using PyMOL, and the surface representations were colored according to the 
hydrophobicity scale defined by Eisenberg et. al. 
 TFG inhibitors 1, 3, and 4 bind the active site of CAII in typical fashion for 
arylsulfonamides: the sulfonamidate (N) coordinates to the catalytic Zn2+ and donates a 
hydrogen bond to the hydroxyl oxygen of T199, and a sulfonamide oxygen accepts a 
hydrogen bond from the backbone amide nitrogen of T199. The butyl tails of inhibitors 3 
and 4 are both disordered, and, interestingly, whereas the inhibitor tail of 3 adopts only the 
trans-amide conformation, the inhibitor tail of 4 appears to adopt both cis- and trans-amide 
conformations. During refinement the cis- and trans-amide conformations of 4 converged 
to occupancies of 0.63 and 0.37, respectively.  
6.4 Conclusions and future directions 
In summary, by exploiting versatile CB[6] host-guest chemistry and facile attachment of a 
CB[6]-binding domain to a protein-binding moiety, we were able to generate novel 129Xe 
NMR biosensors. The TFG programs the molecular relay for exquisite control over 
chemical equilibria between several interacting components – CB[6], TFG, target molecule 
and Xe. This strategy produces CB[6]-129Xe NMR signal, which improves upon our 
previous “turn-off” approach with CB[6],169 and also makes it possible to “target” CB[6] 
for specific biomolecule detection. In the Hyper-CEST setup, because Xe (~136 µM, all 
isotopes) is more abundant than other components, ligand with higher affinity to CB[6] is 
101 
desirable for suppressing Xe binding, thus producing greater contrast when analyte is 
present. In general, analyte detection sensitivity should be maximized when the TFG is 
engineered to achieve well discriminated binding affinities: analyte-TFG >> CB[6]-TFG 
>> CB[6]-Xe. The thermodynamic and kinetic stability of the starting CB[6]-TFG complex 
will hold additional significance in future in vivo applications for molecular imaging.  
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Figure 6.1: Molecular relay produces 129Xe NMR signal upon analyte detection. 
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Table 6.1: Two-faced guests used in this study and thermodynamic data for binding to 
CB[6], CAII, or avidin. 
 
TFG Host  KD 
(µM) 
∆H 
(kcal/mol) 
T∆S 
(kcal/mol) 
∆G 
(kcal/mol) 
1 
CB[6] 4.07 ± 0.55 -1.17 ± 0.02 6.24 -7.41 
CAII 1.11 ± 0.29 1.23 ± 0.03 9.39 -8.16 
2 
CB[6] 6.58 ± 0.89 -0.91 ± 0.03 6.21 -7.12 
CAII 2.29 ± 0.46 -2.19 ± 0.08 5.55 -7.74 
3 
CB[6] 5.55 ± 0.72 -2.33 ± 0.05 4.89 -7.22 
CAII 1.00 ± 0.14 -3.86 ± 0.06 4.38 -8.24 
4 
CB[6] 3.61 ± 0.90 -2.08 ± 0.10 5.40 -7.48 
CAII 0.48 ± 0.07 -2.22 ± 0.02 6.45 -8.67 
5 
CB[6] 236 ± 30 -4.79 ± 0.66 0.20 -4.99 
Avidin [a] ≈ 10-9 N.D. N.D. ≈ -20 
[a] Estimated values shown are based on measurements from ref. 21. 
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Figure 6.2: ITC Data for butylamine binding to CB[6] (a), 1 to CB[6] (b), 2 to CB[6] (c), 
3 to CB[6] (d), 4 to CB[6] (e), 5 to CB[6] (f), 1 to CAII (g), 2 to CAII (h), 3 to CAII (i), 4 
to CAII (j). 
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Figure 6.3: X-ray crystal structure of TFG 1 bound to CAII. (Left) simulated annealing 
omit map (contoured at 2.1) showing 1 bound in the active site of CAII. Coordination 
bonds are shown as dashed black lines and hydrogen bonds are shown as solid black lines. 
The active site Zn2+ is shown as a green sphere. (Right) The active site channel of CAII 
represented as a surface model (hydrophobic residues in red; hydrophilic residues in white). 
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Figure 6.4: X-ray crystal structure of TFG 3 bound to CAII. (Left) Simulated annealing 
omit map (contoured at 3) shows 3 bound to Zn2+ (green sphere) in the active site of CAII. 
Interatomic distances (solid purple lines) are labeled in Å. Water molecules are omitted for 
clarity. (Right) CAII active-site channel is represented as a surface model (hydrophobic 
residues in red; hydrophilic residues in white). 
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Figure 6.5: Modelling of TFG 3 bound to CAII.  (Left) simulated annealing omit map 
(contoured at 3) showing 3 bound in the active site of CAII. Coordination bonds are 
shown as dashed black lines and hydrogen bonds are shown as solid black lines. The active 
site Zn2+ is shown as a green sphere. (Right) Modeling CB[6] binding to the CAII-TFG4 
complex showing steric clash between CB[6] and CAII, top view and side view. 
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Figure 6.6: X-ray crystal structure of TFG 4 bound to CAII. (Left) simulated annealing 
omit map (contoured at 2.5) showing 4 bound in the active site of CAII. Coordination 
bonds are shown as dashed black lines and hydrogen bonds are shown as solid black lines. 
The active site Zn2+ is shown as a green sphere. (Right) The active site channel of CAII 
represented as a surface model (hydrophobic residues in red; hydrophilic residues in white). 
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Figure 6.7: Comparison of CAII esterase activity with different TFGs and CB[6]-TFG 
complexes monitored using pNPA as substrate. All assays were performed after 20 min 
incubation. Standard errors were determined from three or more replicates for each 
condition. 
 
112 
 
 
Figure 6.8: CAII esterase activity in the presence of different ratios of TFG 4 and CB[6]. 
Sample composition 1: 5µM CAII; 2: 5µM CAII + 10µM TFG 4; 3: 5µM CAII + 10µM 
TFG 4+ 10µM CB[6]; 4: 5µM CAII + 10µM TFG 4+ 20µM CB[6]; 5: 5µM CAII + 
10µM TFG 4+ 50µM CB[6]; 6: 5µM CAII + 10µM TFG 4+ 100µM CB[6]; 7: 5µM CAII 
+ 10µM TFG 4+ 200µM CB[6]; 8: 5µM CAII + 10µM TFG 4+ 500µM CB[6]. Standard 
errors were determined from three or more replicates for each condition. 
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Figure 6.9: Frequency-dependent 129Xe NMR saturation spectra in pH 7.2 PBS at 300 K 
showed CAII detection via CB[6]-4 molecular relay. 
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Figure 6.10: Frequency-dependent 129Xe NMR saturation spectra in pH 7.2 PBS at 300 K 
showed avidin detection via CB[6]-pAB molecular relay. 
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Figure 6.11: SDS-PAGE profile Lane 1: standard protein ladder; Lanes 2- 6 contain 0.6, 
0.6, 0.9, 1.2, 2.0 µg of purified protein. Lanes 7 and 8 contain 20 µL control E.coli lysate 
with OD600nm = 0.5 and 1. Lanes 9 and 10 contain 20 µL transformed and induced E.coli 
lysate with OD600nm = 0.5 and 1. Analysis of band intensity showed that Lane 9 contains 
0.6 µg CAII and Lane 10 contains 1.2 µg CAII (2.07 µM).  
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Figure 6.12: Frequency-dependent 129Xe NMR saturation spectra showed CAII detection 
via CB[6]-4 relay in bacterial lysate (OD600nm = 2) at 300 K. 
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Figure 6.13: Synthetic methods for TFGs 
  
118 
Table 6.2: Data collection and refinement statistics for crystallography 
 
 CAII–1 complex CAII–3 complex CAII–4 complex 
Unit cell    
space group symmetry P21 P21 P21 
a, b, c (Å) 42.4, 41.4, 72.1 42.4, 41.4, 72.1 42.3, 41.4, 72.0 
α, β, γ () 90.0, 104.0, 90.0 90.0, 104.2, 90.0 90.0, 104.1, 90.0 
    
Data collectiona    
wavelength (Å) 1.282 0.979 1.282 
resolution limits (Å) 41.4-1.34 41.4-1.13 41.4-1.33 
total/unique reflections 388992/51140 631318/87628 400949/52900 
Rmergeb 0.047 (0.235) 0.080 (0.372) 0.048 (0.198) 
I/σ(I) 24.2 (7.8) 17.4 (7.4) 23.6 (8.9) 
CC1/2 0.999 (0.969) 0.996 (0.922) 0.999 (0.977) 
multiplicity 7.6 (7.6) 7.2 (6.1) 7.6 (7.5) 
completeness (%) 93.8 (88.6) 96.6 (92.8) 95.3 (91.7) 
    
Refinement    
reflections used in       
refinement/test set 100221/5042 172159/8740 103676/5244 
Rworkc 0.137 0.134 0.142 
Rfreed 0.162 0.151 0.167 
protein atoms 2038 2045 2029 
water molecules 255 272 231 
ligand molecules 1 1 1 
Zn2+ ions 1 1 1 
Na+ ions 1 1 1 
glycerol molecules 1 1 1 
    
R.m.s. deviations from 
ideal geometry    
bonds (Å) 0.005 0.005 0.006 
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angles (°) 1.1 1.2 1.2 
dihedral angles (°) 12.8 12.7 13.7 
    
Average B-factors (Å2)    
Protein 11 9 11 
Solvent 25 22 24 
Ligand 15 15 13 
Zn2+ 11 4 11 
    
Ramachandran plot 
(%)e    
favored 96.9 96.5 97.3 
allowed 3.1 3.5 2.7 
outliers 0 0 0 
    
PDB accession code 5EKH 5EKJ 5EKM 
a Values in parentheses refer to the highest shell of data.  
b Rmerge = Ih - Ih/Ih, where Ih is the average intensity for reflection h calculated from 
replicate reflections. c Rwork = |Fo| - |Fc|/|Fo| for reflections contained in the working set. 
Fo and Fc are the observed and calculated structure factor amplitudes, respectively.  
d Rfree = |Fo| - |Fc|/|Fo| for reflections contained in the test set held aside during 
refinement.   
e Calculated with MolProbity. 
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Figure 6.14: 1H NMR and 13C NMR spectra of compounds synthesized in this study 
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Figure 6.15: High-resolution mass spectra of compounds synthesized in this study 
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CHAPTER 7 A GENETICALLY ENCODED Β-LACTAMASE REPORTER FOR 
ULTRASENSITIVE 129XE NMR IN MAMMALIAN CELLS 
Adapted from Yanfei Wang, Benjamin W. Roose, Eugene J. Palovcak, Vincenzo 
Carnevale, and Ivan J. Dmochowski, Angew.Chem. Int.Ed., 2016, DOI: 
10.1002/anie.201604055R1 and 10.1002/ange.201604055R1, in press.198 
7.1 Introduction 
Genetically encoded optical reporters such as green fluorescent protein (GFP) have enabled 
biomolecular imaging, making it possible to connect cellular processes with quantitative, 
real-time measurements of localized gene expression.199 However, due to the strong 
scattering of light by living tissue, optical reporters are mostly limited to studies of single 
cells and transparent, model organisms. Alternate non-invasive imaging methods such as 
magnetic resonance imaging are thus needed for monitoring gene expression and tracking 
cell migration in larger organisms.200-202 MRI offers excellent spatiotemporal resolution, 
however 1H MRI reporter genes are limited by low detection sensitivity and also by high 
background 1H signals from water and fat. This has motivated investigation of 
hyperpolarized 129Xe (I = ½), which can provide Xe-specific molecular information within 
the context of 1H NMR signals. 
Recently, Shapiro et al. reported the use of genetically encoded bacterial gas vesicles 
(GVs) as ultrasensitive Hyper-CEST contrast agents.57 While providing a pioneering 
example, GVs are very large (0.1 – 2 µm long) multimeric protein assemblies from 
complex gene clusters, and difficult to reconstitute in many eukaryotic systems. Here we 
show that the 29 kDa TEM-1 β-lactamase from E. coli can function as a genetically 
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encoded single-protein contrast agent for Hyper-CEST, and gives useful contrast in both 
bacterial and mammalian cells (Figure 7.1). 
The small size (D = 4.3 Å) and hydrophobicity of xenon allow it to interact with 
proteins via both non-specific and specific binding events.203,204 Previous 129Xe NMR 
studies have probed hydrophobic cavities within globular proteins.143,144,146,205,206 The 
promiscuous interactions of xenon with many proteins have also been investigated by the 
X-ray diffraction of protein crystals under high Xe pressure, where xenon can occupy 
hydrophobic cavities, substrate-binding sites, and also channel pores.207 Notably, these are 
weak interactions, with hemoglobin and myoglobin exhibiting the highest reported xenon 
association constants of around 200 M-1 at rt.208,209 In our search for a versatile genetically 
encoded reporter for Hyper-CEST NMR, we targeted a candidate protein TEM-1 β-
lactamase (bla) based on its well-established allosteric site whose size and hydrophobicity 
suggest it to be a good target for Xe exchange. In 2004, the allosteric site was discovered 
serendipitously via X-ray crystallography,210 and additional cryptic allosteric sites were 
recently identified in molecular dynamics (MD) simulations analyzed using Markov State 
Models.211,212 Bla is a small, monomeric bacterial enzyme that hydrolyzes β-lactam 
antibiotics and confers antibiotic resistance to its host. Importantly, bla is not normally 
found in eukaryotic cells and is nontoxic when overexpressed in eukaryotic cells.213,214 The 
activity that bla confers initially motivated the development of fluorogenic substrates for 
studies of gene expression in mammalian cell culture.215 Bla has since been widely applied 
in biotechnology, e.g., in protein fragment complementation assays for studying protein-
protein interactions in vitro and in vivo,216-218 with constructs engineered to be minimally 
immunogenic, and in transgenic bla-mouse reporters.219 
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7.2 Results and discussion 
7.2.1 MD simulations 
To explore whether bla is able to accommodate Xe atoms, we performed "flooding" MD 
simulations. In this protocol, the protein is simulated in the presence of a large number of 
solute moieties to increase the rate of collisions between the solute and protein and thus 
enhance the sampling of binding events. In particular, we simulated bla in presence of Xe 
atoms (0.15 M) dissolved in water. Characterization of the protein regions visited by Xe 
atoms during the simulation gives information about the putative binding sites, pathways, 
and relative binding kinetics. 
The analysis of a 1-µs trajectory reveals a complex landscape with numerous bla 
regions characterized by a large value of Xe occupancy (Figure 7.2). The most prominent 
binding region is located between the two terminal α-helices (one at the N-terminus and 
the other at the C-terminus: residues 26 to 41 and 272 to 290, respectively) and the flanking 
β sheet; where Xe atoms are observed to form a cluster of up to 4 atoms (Figure 7.2 and 
7.3a). Strikingly, this is the same allosteric site that had been characterized 
crystallographically (Figure 7.4).210 Five other regions with comparable occupancy but 
smaller size are detected throughout the protein, all of them in proximity of helix 2 
(residues 67 to 87).  
The location and extension of these high-Xe-occupancy regions (Figure 7.5) bear 
striking resemblance to the cryptic allosteric sites detected by Geissler211 on a large 
sampling of protein conformations collected via Markov State Models, which included the 
experimentally validated allosteric binding site.210 In this relatively large, hydrophobic 
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cavity, Xe atoms establish van der Waals interactions with the sidechains of several 
residues (V33, V44, R244, I246, V261, I263, T265, I279, L286). R244 and T265 are the 
only polar residues in this pocket (Figure 7.3a). As previously noted,211 the side chains that 
form this primary cavity also interact with allosteric bla inhibitors.210  
Our simulations provide insight on the relative binding kinetics of Xe to this 
allosteric site. Indeed, we found that binding to the innermost section of this cavity (located 
between helix 1 and 12) occurs after ~0.6 µs and only after the most solvent accessible part 
of the cavity (lined by helix 11 and 12) is fully occupied by two Xe atoms (Figure 7.2b). 
Thus, in spite of the high concentration of Xe atoms, binding to the allosteric pocket is a 
relatively slow process, slower than binding to any other pocket present in bla (Figure 7.6). 
7.2.2 Hyper-CEST experiments 
For in vitro studies, recombinant bla was expressed in BL21(DE3) E. coli and purified by 
column chromatography. Bla (80 µM) was used to obtain a Hyper-CEST z-spectrum, 
where multiple selective Dsnob-shaped saturation pulses were scanned over the chemical 
shift range of 143-293 ppm in 5-ppm steps, and aqueous 129Xe signal was measured as a 
function of saturation pulse offset (Figure 7.3b and Figure 7.7). Two saturation responses 
were observed: one for free 129Xe in solution peak centered at 195 ppm, and a second peak 
centered at 255 ppm that was attributed to xenon-bla interaction. Both peaks in the Hyper-
CEST z-spectrum appeared broad, indicating that xenon undergoes fast exchange between 
the aqueous state and transient protein-binding state. Importantly, the unique 129Xe-bla 
peak cannot be directly observed by hp 129Xe NMR spectroscopy even with high-
concentration (~mM) bla, due to the low xenon-bound population and high rate of xenon 
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exchange between different sites. This scenario was observed previously with spores48 and 
also CB[6].220 
We then carried out Hyper-CEST measurements by varying saturation time to 
determine the molecular sensitivity of bla. Shaped saturation pulses were applied at the 
chemical shift of 129Xe-bla, and the residual aqueous 129Xe signal after saturation transfer 
was measured as on-resonance CEST response (Figure 7.7 and 7.8). Off-resonance pulses 
were applied at 135 ppm, to mirror the 60-ppm frequency interval observed for Xe-bla and 
Xe-aq signals. The observed depolarization response in Hyper-CEST experiments arose 
from both self-relaxation of hp 129Xe and bla-mediated saturation transfer. The normalized 
difference between on-resonance and off-resonance signals was represented by the 
saturation contrast. Using this method, 0.1 µM (2.9 µg/mL) bla was able to produce 0.23 
± 0.02 saturation contrast (Equation 4.1). The in vitro detection limit of single protein bla 
is comparable to previously reported GVs in terms of protein mass concentration,57 and 
represents a roughly 100-fold improvement compared to 1H-CEST reporter genes.221  
7.2.3 Site mutagenesis 
We hypothesized that the 255 ppm peak observed in the Hyper-CEST spectrum may 
originate from the allosteric cavity (Figure 7.2b) identified by MD simulations. Ile-263 is 
positioned at the entrance of this Xe binding site and lies in close proximity to the bound 
Xe (Figure 7.3a). Thus, Ile-263 was mutated to alanine, and the I263A mutant was 
expressed and purified following the same procedure used for wild-type (wt) bla. The 
Hyper-CEST z-spectrum for I263A showed almost complete loss of the Xe-bla signal 
(Figure 7.3b). Following Hyper-CEST, an activity assay confirmed that the I263A enzyme 
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was not denatured by Xe bubbling during the Hyper-CEST experiments. Additionally, 
circular dichroism (CD) spectroscopy confirmed that the secondary structure of the I263A 
mutant was maintained (Figure 7.9). The loss of Hyper-CEST signal at 255 ppm is 
attributed to faster Xe exchange and/or lower Xe affinity for the larger I263A cavity. This 
highlights that the architecture of the wt-bla allosteric site is crucial for producing Hyper-
CEST signal. 
7.2.4 Cell studies 
We then investigated the possibility of using bla as a genetically encoded 129Xe NMR 
reporter in cells. BL21(DE3) E. coli cells expressing recombinant wt-bla were cultured in 
LB media and induced with 2 mM isopropyl-β-thiogalactopyranoside (IPTG). Cells were 
then pelleted, washed, resuspended in phosphate-buffered saline (PBS), and used in Hyper-
CEST experiments. E. coli cells transformed with the same plasmid but not induced by 
IPTG were prepared following the same procedure as a negative control. Saturation time-
dependent Hyper-CEST experiments showed that bla-expressing E. coli grown to OD600 of 
9.2 (7.4 billion cells/mL) produced a saturation contrast of 0.72 ± 0.03 (Figure 7.10a). After 
6.7 s of nearly continuous irradiation of 129Xe-bla with saturating RF pulses, the 129Xe-aq 
peak was almost completely saturated. By contrast, the on-resonance and off-resonance 
curves were almost identical for the control E. coli sample at the same OD600. The same 
result was observed in the z-spectra of induced and non-induced E. coli cells (Figure 7.11). 
In these E. coli experiments, bla was readily detected at the equivalent of 6.5 µM 
concentration in the cell suspension, as confirmed by gel and colorimetric assay (Figure 
7.12). 
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Having established that bla can be used as a genetically encoded reporter in a 
bacterial system, we set out to test whether it can also function in mammalian cells. 
HEK293T/17 cells were transfected with a transient-expression plasmid incorporating 
SV40 enhancer, harvested, and resuspended in PBS for Hyper-CEST experiments. Control 
cells were sub-cultured from the same flask but not transfected. At 4.4 million cells per mL 
concentration, without optimization for bla expression, both transfected and non-
transfected cells produced obvious saturation contrast, and both z-spectra had a slight 
shoulder appearing in the downfield region of the 129Xe-aq peak (Figure 7.13). We 
hypothesize this background signal arises from the interaction of xenon with membranes 
enclosing the organelles in eukaryotic cells,32,38 which are absent in prokaryotic cells. In 
order to minimize background contrast, we compared Hyper-CEST signal of samples at 
lower cell density while increasing the bla expression level. As illustrated by Figure 7.10c, 
0.2 million/mL transfected HEK cells producing the equivalent of 0.7 µM bla in the cell 
suspension (Figure 7.14) was sufficient to produce a saturation contrast of 0.13 ± 0.01, 
compared to minimal contrast observed for control HEK cells. 
7.3 Methods 
7.3.1 MD simulation 
The molecular dynamics simulation was initialized using the X-ray crystal structure of 
bla.222 The molecular system contained a total of 67970 atoms, including bla, 21,238 water 
molecules, 127 ions in solution and 60 Xe atoms. The resulting initial aqueous 
concentration of Xe is 155 mM. The simulation was performed using the CHARMM22-
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CMAP force field with torsional cross-terms for the protein.223,224 The water molecules 
were described using the TIP3P model.225 Periodic boundary conditions were employed 
for all of the MD simulations and the electrostatic potential was evaluated using the 
particle-mesh Ewald method.226 The lengths of all bonds containing hydrogen were 
constrained with the SHAKE/RATTLE algorithm.227 The system was maintained at a 
temperature of 300 K and pressure of 1 atm using the Langevin thermostat and barostat 
methods as implemented in the MD code NAMD2.10.228 The rRESPA multiple time step 
method was employed, with a high frequency timestep of 2.0 fs and a low frequency time 
step of 4.0 fs. 
7.3.2 Sample preparation 
A pJ411 vector containing a codon-optimized coding sequence for E. coli TEM-1 β-
lactamase (UniProt accession number P62593) was purchased from DNA 2.0. The bla 
plasmid was transformed into E. coli BL21(DE3) competent cells (New England BioLabs) 
and grown on LB-agar plates supplemented with 50 μg/mL kanamycin. 1 L cultures of 
transformed cells were grown in LB media supplemented with 50 μg/mL kanamycin at 37 
°C until reaching an OD600 of approximately 0.8. Protein expression was induced with 2 
mM isopropyl-β-thiogalactopyranoside (IPTG) (Carbosynth) overnight at 18 °C. 
For expression of bla in HEK cells, a transient-expression vector with a CMV 
promoter and SV40 enhancer (vector name pD2610-v12) containing a codon-optimized 
coding sequence for E. coli TEM-1 β-lactamase was purchased from DNA 2.0. The 
HEK293T/17 cells were cultured in T25 flask in high L-glutamine DMEM media 
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supplemented with fetal bovine serum (FBS) and antibiotics until reaching about 80% 
confluency. Cells were subsequently transfected with the pD2610 plasmid using 
Lipofectamine 3000 reagent (Thermo Fisher). After 3 days, cells were harvested and 
resuspended in PBS.  
7.3.3 Hyperpolarized 129Xe chemical exchange saturation transfer 
Hyper-CEST experiments were performed using an 11.7-T spectrometer with 10-mm 
probe. hp 129Xe was generated using spin-exchange optical pumping (SEOP) method with 
home-built 129Xe hyperpolarizer generating roughly 10% hyperpolarized 129Xe, as 
described elsewhere.53 A gas mixture (total pressure 50 psi) of 10% nitrogen, 89% helium, 
and 1% natural abundance xenon (Linde Group, NJ) was used as the hyperpolarizer input. 
Xenon concentration is 0.14 mM. For each data point in the Hyper-CEST spectrum, the 
output gas mixture from the hyperpolarizer was bubbled into NMR tube through capillaries 
for 20 sec, followed by a 3-sec delay to allow bubbles to collapse. For Hyper-CEST z-
spectra (Figure 3b and Figure 7.7 left), a saturation train of 600 dSNOB pulses (690 Hz 
bandwidth) with 0.1ms delay in between was used: Pulse length tpulse = 3.80 ms, field 
strength B1,max = 77 µT, number of pulses npulse= 600. Saturation contrast represents the 
normalized difference between on- and off-resonance signals in saturation time dependent 
Hyper-CEST experiments. For all experiments, 0.01 -0.1% (v/v) Pluronic L81 (Aldrich) 
was added to mitigate foaming. 
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7.3.4 TEM-1 bla expression and purification 
A pJ411 vector containing the codon-optimized coding sequence for TEM-1 β-lactamase 
(bla) from Escherichia coli (UniProt accession P62593) was purchased from DNA 2.0. A 
M182T substitution was incorporated into the bla gene to stabilize the native state of the 
protein.229 
BL21(DE3) E. coli competent cells were transformed with the bla-pJ411 plasmid 
and cultured on a LB-agar plate supplemented with 50 µg/mL kanamycin. Single colonies 
of transformed cells were used to inoculate 5 mL of LB medium supplemented with 50 
µg/mL kanamycin. The 5 mL cultures were incubated overnight at 37 °C with shaking at 
250 rpm. The 5 mL cultures were used to inoculate 6 x 1 L of LB medium supplemented 
with 50 µg/mL kanamycin in baffled culture flasks. The 1 L cell cultures were incubated 
at 37 °C with shaking at 250 rpm until OD600 reached ~0.7. Protein expression was induced 
by adding isopropyl-β-D-thiogalactopyranoside (IPTG) to a final concentration of 1 mM. 
The induced cultures were incubated overnight at 18 °C with shaking at 250 rpm. The cells 
were pelleted by centrifugation and frozen at -80 °C for long-term storage. 
The cells were lysed by one round of freeze-thaw lysis230 in 50 mM Tris (pH 8.0), 
10% (v/v) glycerol. The lysate was clarified by centrifugation and the supernatant was 
loaded onto three 5 mL HiTrap Q hp anion-exchange columns (GE Healthcare Life 
Sciences) connected in series and pre-equilibrated with 50 mM Tris (pH 8.0), 10% (v/v) 
glycerol. Protein was eluted from the column with 50 mM Tris (pH 8.0), 10% (v/v) glycerol 
supplemented with 3.0 M NaCl. The flow-through and eluted fractions were evaluated by 
SDS-PAGE, and fractions containing bla were pooled, concentrated, and then loaded onto 
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a HiLoad 16/600 Superdex size-exclusion column (GE Healthcare Life Sciences) pre-
equilibrated with 50 mM Tris (pH 7.4). Fractions containing pure bla were pooled, and 
analysis by SDS-PAGE indicated that the protein was over 95% pure. Protein concentration 
was determined by measuring absorbance at 280 nm using the extinction coefficient (ε280 
= 28 085 M-1 cm-1) calculated by the PROTPARAM server.231 
7.3.5 Bla(I263A) preparation 
The I263A mutation to bla was introduced into the bla-pJ411 plasmid via site-directed 
mutagenesis. The oligonucleotide primers used were: 5' – 
GCATTGTTGTGGCGTATACCACCGG – 3' (sense) and 5' – 
CCGGTGGTATACGCCACAACAATGC – 3' (antisense). The mutated bla gene was 
sequenced to confirm the incorporation of the I263A mutation and verify the integrity of 
the rest of the gene sequence. The bla-I263A mutant was expressed and purified following 
the same procedure used for wt-bla. 
7.3.6 Circular dichroism (CD) spectroscopy 
The CD spectra of wt-bla and bla(I263A) were collected on a AVIV model 425 circular 
dichroism spectrometer using a 1 mm quartz cuvette. The samples consisted of 10 µM 
enzyme in 10 mM sodium phosphate (pH 8.0) buffer. The CD spectra were acquired at 25 
°C with a wavelength step of 1 nm. 
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7.3.7 Activity assay of bla(I263A) pre- and post-CEST 
The hydrolase activity of 5 nM bla(I263A) was measured in 50 mM Tris (pH 7.4), 5% (v/v) 
DMSO using 450 µM nitrocefin (EMD Millipore) as a substrate. The hydrolysis of 
nitrocefin was monitored at A482 using an Infinite M1000 Pro plate reader (Tecan). The 
activity assays were performed in triplicate for pre- and post-CEST bla(I263A). The initial 
rates measured for pre- and post-CEST bla(I263A) were 0.142 ± 0.002 A482 min-1 and 
0.153 ± 0.009 A482 min-1, respectively. 
7.3.8 Expression of TEM-1 bla in E. coli  
BL21(DE3) E. coli competent cells were transformed with the bla-pJ411 plasmid and 
cultured on a LB-agar plate supplemented with 50 µg/mL kanamycin. A single colony of 
transformed cells was used to inoculate 5 mL of LB medium supplemented with 50 µg/mL 
kanamycin. The 5 mL culture was incubated overnight at 25 °C with shaking at 250 rpm. 
The next morning the cells were pelleted and resuspended in 2 mL of fresh LB. The 
resuspended cells were used to inoculate 2 x 1 L of LB medium supplemented with 50 
µg/mL kanamycin in baffled culture flasks. The 1 L cell cultures were incubated at 37 °C 
with shaking at 250 rpm until OD600 reached ~0.7, at which point the control flask was 
stored at 4 ° C and the other flask was induced by adding IPTG to a final concentration of 
2 mM. The induced culture flask was incubated overnight at 18 °C with shaking at 250 rpm 
and then stored at 4 °C.Aliquots from the control and induced cultures were centrifuged 
and the cell pellets were resuspended in PBS buffer. To measure the concentration of bla 
present in the E. coli cell suspension, the cells were diluted to an OD600 of 3 in PBS buffer 
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and then lysed by five rounds of freeze/thaw lysis. The lysate was clarified and the 
supernatants were stored at 4 °C. The concentration of bla was measured by both 
quantitative SDS-PAGE (Figure 7.12) and by measuring enzyme activity. For the SDS-
PAGE analysis, the supernatants from the control and induced growths were ran on a 
NuPAGE 12% Bis-Tris gel (Invitrogen). Previously-purified bla at known concentrations 
served as standards. The gel was developed using a Pierce Silver Stain Kit (Thermo 
Scientific) and imaged on a Typhoon FLA 7000 laser scanner (GE Healthcare Life 
Sciences). The intensity of the bla bands were quantified using the ImageQuant TL 
software package (GE Healthcare Life Sciences).  
Bla activity was measured in 50 mM Tris (pH 7.4), 5% (v/v) DMSO using 500 µM 
nitrocefin (EMD Millipore) as a substrate. The hydrolysis of nitrocefin was monitored at 
A482 using an Infinite M1000 Pro plate reader (Tecan), with the hydrolase activity of 2 
nM bla serving as a standard. The activity assays were performed in triplicate, and gave 
the same bla expression level as seen by SDS-PAGE, which was 0.7 µM normalized to 
OD600=1. 
7.3.9 Transient expression of TEM-1 bla in HEK 293T cells  
A pD2610-v12 vector containing the HEK293T codon-optimized coding sequence for 
mature bla (i.e. without the N-terminal signal peptide) was purchased from DNA 2.0. This 
construct also contained the M182T stabilizing mutation. The bla-pD2610-v12 plasmid 
was amplified in DH10B E. coli and purified using a Qiagen Megaprep kit. Plasmid 
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concentration was measured by A260, and the A260/A280 ratio indicated that the plasmid 
was of high purity.  
HEK293T/17 cells were cultured in T25 flasks in DMEM supplemented with L-
glutamine, 10% fetal bovine serum, 1% penicillin/streptomycin until 80% confluency. The 
medium was then removed and the cells were washed with phosphate-buffered saline. Cells 
were then transfected with 6.25 µg plasmid per flask using lipofectamine 3000 reagent 
(Thermo Fisher). Cells were incubated in the DNA-lipid complex at 37 °C for 3 days. Prior 
to Hyper-CEST experiments, cells were washed with PBS, harvested, and counted with a 
hemocytometer. In order to determine the expression level of bla, HEK293T cells were 
lysed by three freeze-thaw cycles. The lysate was clarified by centrifugation and the 
supernatant was analyzed by colorimetric assay and SDS-PAGE. The bla expression level 
of 0.2 million/mL transfected HEK cells was determined to be equivalent to 0.7 µM bla in 
the cell suspension, which agrees with the level determined by SDS-PAGE gel (Figure 
7.14).  
Cells transfected with a pD2529-CMV vector without SV40 gave expression level 
of 2.7 µM bla for 4.4 million/mL cells, and were used in Figure 7.13. 
7.4 Conclusions and future directions 
This study highlights a potential use for HP 129Xe as an ultrasensitive probe for studying 
cryptic pockets in proteins. Based on the expression level of bla in E.coli and HEK cells 
used in Hyper-CEST experiments, we noticed lower detection sensitivity was achieved 
with bla expressed in cellular environments, compared to pure bla in solution. For instance, 
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the saturation contrast produced by approximately 6.5 µM bla in induced E. coli cell 
suspension was considerably less than the saturation contrast arising from 0.5 µM bla in 
buffer (Figure 7.8), under the same saturation pulse conditions. This can be explained by 
the diffusion barriers imposed by cells, which can result in tens-of-millisecond xenon 
penetration time, according to previous studies.46,47 Nevertheless, 0.7 µM bla expressed by 
0.2 million/mL transfected HEK cells was readily detected using Hyper-CEST.  
MD simulations identified multiple regions with high xenon occupancy, displaying 
different binding kinetics, and suggest a specific xenon pathway for the primary allosteric 
site in bla. Site-directed mutagenesis provided additional evidence for this site. We surmise 
that the observed ‘stepwise’ binding mechanism affords bla Hyper-CEST capability by 
slowing the exchange interaction between xenon and bla and thus allowing for a longer Xe 
residence time within the allosteric site. The pooling of several Xe atoms at the primary 
site may be important for the slow exchange interactions, and also contribute to the unique 
bla-129Xe NMR chemical shift observed at 255 ppm.  
In summary, we demonstrated that TEM-1 bla can function as a genetically encoded 
single-protein reporter for Hyper-CEST NMR, with molecular sensitivity of at least 0.1 
µM in vitro. E. coli experiments confirmed the ability to detect bla expression in a bacterial 
system, where Hyper-CEST data indicate no competing background signal from 
endogenous proteins. The feasibility of bla-based in vivo Hyper-CEST biomolecular 
imaging was further supported by HEK cell experiments, where sub-micromolar levels of 
bla produced useful contrast. Bla has been well established as a fluorogenic reporter for in 
vivo studies, which lends support to its further development as a Hyper-CEST reporter for 
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biomolecular imaging. Use of isotopically enriched 129Xe and new 129Xe hyperpolarization 
technology should increase detection sensitivity more than 10-fold.232,233 We also aim to 
improve bla as a Hyper-CEST reporter for biomolecular imaging: Efforts are underway to 
realize this potential: For example, bla mutagenesis should make it possible to increase Xe 
affinity at the primary site and also shift the Hyper-CEST response peak, either to achieve 
multiplexing or to discriminate further against 129Xe-mammalian cell background signals. 
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Figure 7.1: Ultrasensitive detection of bla via hp 129Xe chemical exchange saturation 
transfer. hp 129Xe (green) exchanges into bla, where the unique resonance frequency can 
be saturated by shaped RF pulses. Saturated xenon (maroon) returns to the bulk, leading to 
a decrease in Xe-aq signal. 
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Figure 7.2: a) Cartoon representation of bla showing secondary structure elements; color 
highlights the position of each residue along the primary structure, from red (N-terminus) 
to blue (C-terminus). The purple volumes indicate regions of high Xe occupancy. b) 
Selected snapshots from the molecular dynamics trajectory after 0.6 µs (top panel) and 1 
µs (bottom panel), highlighting Xe atoms (blue spheres) occupying only the main allosteric 
site. The sidechains of the residues lining the pocket are represented as sticks.  
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Figure 7.3: a) Close-up of the main Xe binding site. Secondary structure elements--helices 
1 and 12 and the flanking beta sheet—are colored red (N-terminus) to blue (C-terminus). 
Xe atoms (blue spheres) establish van der Waals interactions with many sidechains (gray 
sticks). b) Hyper-CEST z-spectra for wt-bla and I263A, 80 µM in pH 7.2 PBS.  
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Figure 7.4: Structural comparison between the Xe binding sites and the crystallographically 
determined allosteric binding sites. The structure of bla after 1-µs of molecular dynamics 
simulation (cyan) is superimposed on the structure of bla in complex with 3-(4-
PHENYLAMINO-PHENYLAMINO)-2-(1H-TETRAZOL- 5-YL)-ACRYLONITRILE 
(A, purple -- PDB code: 1PZP) and N,N-BIS(4-CHLOROBENZYL)-1H-1,2,3,4-
TETRAAZOL-5-AMINE (B, orange -- PDB code: 1PZO). Xe atoms are shown as blue 
spheres, while the allosteric inhibitors are shown as sticks. Note how Xe atoms are found 
in the regions of space occupied by the bulky phenyl moieties.  
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Figure 7.5: Representative snapshots from the "flooding" MD simulation trajectory. 
Secondary structure elements are colored according to the position of each residue in the 
primary structure: from red (N-terminus) to blue (C-terminus), Xe atoms are shown as blue 
spheres. After 0.6 µs, Xe atoms engage in stable interactions with the sidechains from the 
region close to helices 1 and 12.  
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Figure 7.6: Xe atom binding events sampled during the "flooding" MD simulation. A) The 
number of Xe atoms in contact with the protein (closer than 3 Å from any protein atom) is 
shown as a function of time. The blue line shows the centered moving average using a 
window length of 0.2-µs, the dotted and dashed lines highlight the values 13 and 18, 
respectively. Note how after 0.6 µs the number of Xe atoms increases on average by 
approximately five units. Apart from this stepwise increment, fluctuations in the number 
of Xe atoms (binding and unbinding events) occur on time scales smaller than the 
smoothing window (approximately 0.1 µs). B) Number of Xe atoms bound to the main 
binding site (defined as the region surrounded by the sidechains of residues 33, 44, 244, 
246, 261, 263, 265, 286 and 279). The number of ions bound to these regions increase by 
two or three units after 0.6 µs. C) Same plot as in B) for a different binding region (cavity 
surrounded by sidechains of residues 68, 72 and 172). Note how in this case the binding is 
only transient.  
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Figure 7.7: Hyper-CEST spectra of wt-bla. Left: Hyper-CEST frequency-scan profile of 
80 µM bla in pH 7.2 PBS at 300 K. The black squares show the experimental data, and the 
lines show the exponential Lorentzian fits. Right: Representative Hyper-CEST profile of 
0.1 µM bla in pH 7.2 PBS at 300 K. Saturation frequencies of Dsnob-shaped pulses were 
positioned +60 ppm and -60 ppm referenced to Xe-aq peak, for on- and off-resonance. 
Pulse length, τpulse = 0.759 ms; field strength, B1,max = 385 µT. Both on-resonance and 
off-resonance data were fitted with first-order exponential decay curves, with ton = 18.9 ± 
0.1 sec and toff = 35.5 ± 1.1 sec.  
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Figure 7.8: Representative Hyper-CEST profile of 0.5 µM bla in pH 7.2 PBS at 300 K. 
Saturation frequencies of Dsnob-shaped pulses were positioned +60 ppm and -60ppm 
referenced to Xe(aq) peak, for on- and off-resonance. Pulse length, τpulse = 1.0496 ms; field 
strength, B1,max = 279 µT 
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Figure 7.9: CD spectra of bla(I263A) before and after Xe Hyper-CEST. The CD spectrum 
of wt-bla is shown as a reference. 
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Figure 7.10: Top: Time-dependent saturation transfer data for induced E. coli (left) and 
non-induced E. coli (right). Bottom: Time-dependent saturation transfer data for 
transfected (left) and control (right) HEK293T/17 cells. Saturation frequencies of Dsnob-
shaped pulses were positioned +60 ppm and -60ppm referenced to Xe-aq peak, for on- and 
off-resonance. Pulse length, τpulse = 1.0496 ms; field strength, B1,max = 279 µT. The number 
of pulses linearly increased from 0 to 6000, 12000 or 14000. 
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Figure 7.11: Hyper-CEST frequency-scan profile of induced and control E. coli at OD600 
= 9.2. 
 
  
300 280 260 240 220 200 180 160 140
0.0
0.2
0.4
0.6
0.8
1.0
 E. coli expressing bla
 control E. coli
P
os
t s
at
ur
at
io
n 
X
e(
aq
) s
ig
na
l
Saturation frequency (ppm)
159 
 
 
Figure 7.12: SDS-PAGE to quantify bla expression level in E. coli. Lanes 1-3: Lysate from 
induced E. coli (normalized to OD600 = 3). The heavier bands right above mature bla bands 
correspond to the bla with N-terminal signal peptide uncleaved; Lane 4: Lysate from non-
induced E. coli (normalized to OD600 = 3. Lanes 5-10 contain 0.0725, 0.145, 0.29, 0.58, 
0.87, 1.16 µg of purified bla. Analysis of band intensity showed that Lane 1-3 contains 
0.62 ±0.13 µg bla, which corresponds to 0.71±0.15 µM for E. coli at OD600 = 1. 
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Figure 7.13: Hyper-CEST frequency-scan profile of transfected and control HEK293T 
cells at 4.4 million/mL concentration. Control_hek_ST (blue triangle) and bla_hek_ST 
(purple triangle) represent the difference of signal intensity for each pair of offset frequency 
with reference to 129Xe-H2O peak, S- ∆w -S+ ∆w (∆w = 5,10,…85 ppm), for control HEK cells 
and transfected cells, respectively.  
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Figure 7.14: SDS-PAGE to quantify bla expression level in HEK293T cells. Lane 1: 
Precision plus protein standards (Bio-Rad). Lanes 2 -6 contain 0.3, 0.6, 1.2, 2.4, 3.6 µg of 
purified bla. Lane 7: 20 µL lysate of control HEK cells at 0.6 million/ml. Lanes 8-10: 20 
µL lysate of transfected HEK cells at 0.6 million/mL. Gel was developed using Coomassie 
Blue and imaged on a Typhoon FLA 7000 laser scanner. Analysis of band intensity showed 
that Lanes 8-10 contain 1.25 ± 0.16 µg corresponding to 3.6 ± 0.5 µM expression level for 
1million/mL transfected HEK cells. 
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APPENDIX  
I. Pulse sequence for 2D-EXSY 
;used with parameters discussed in Chapter 5. 
;2D homonuclear correlation via chemical exchange. 
;noesyph, avance-version (00/02/07);phase sensitive 
; Three 90-degree pulses separated by 2 delays d0 and d8 
; Note that delay d0 is incremented 
 
;$CLASS=HighRes 
;$DIM=2D 
;$TYPE= 
;$SUBTYPE= 
;$COMMENT= 
#include <Avance.incl> 
"d0=in0/2-p1*4/3.1416" 
1 ze 
2 d1 
3 p1 ph1 
  d0 
  p1 ph2 
  d8 
  p1 ph3 
  go=2 ph31 
  d1 mc #0 to 2 F1PH(ip1, id0) 
exit 
 
ph1=0 2  
ph2=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 
ph3=0 0 2 2 1 1 3 3 
ph31=0 2 2 0 1 3 3 1 2 0 0 2 3 1 1 3 
 
;pl1 : f1 channel - power level for pulse (default) 
;p1 : f1 channel -  90 degree high power pulse 
;d0 : incremented delay (2D) 
;d1 : relaxation delay; 1-5 * T1 for thermally polarized nuclei 
;d8 : mixing time. Adjusted according to the exchange kinetics of 
the system 
;in0: 1/(1 * SW) = 2 * DW 
;nd0: 1 
;NS: 8 * n 
;DS: 16 
;td1: number of experiments 
;FnMODE: States-TPPI, TPPI, States or QSEQ 
 
;Processing 
;PHC0(F1): 90 
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;PHC1(F1): -180 
;FCOR(F1): 1 
II. Pulse sequence for Hyper-CEST 
; used with AU programs, for example, Appendix III. 
;zgps_hyper_cest 
;1D sequence using shaped pulse for pre-saturation 
;Observe at f1 with a hard pulse 
 
; parameters below need to be specified 
; p1: 90-degree high power pulse duration 
; pl1: f1 channel - power level for pulse (default) 
; sp6: power level for shaped pulse for pre-saturation 
; p18: shaped pulse (for pre-saturation) duration 
 
;$CLASS=HighRes 
;$DIM=1D 
;$TYPE= 
;$SUBTYPE= 
;$COMMENT= 
#include <Avance.incl> 
 
"d12=20u" 
"acqt0=-p1*2/3.1416" 
1 ze 
2 d1 
d12 fq=cnst20:f1 
3 (p18:sp6 ph29):f1 
d6 
lo to 3 times l6 
d12 pl1:f1 fq=0:f1 
p1 ph1 
go=2 ph31 
30m mc #0 to 2 F0(zd) 
exit 
ph1=0 2 2 0 1 3 3 1 
ph29=0 
ph31=0 2 2 0 1 3 3 1 
 
;d12: delay for power switching [20 usec] 
;l6: p18 * l6 = total duration of presaturation 
;NS: 1 * n, total number of scans: NS * TD0 
;use 100msec pulse of square shape defined by 1000 points 
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III. Representative automation program for Topspin 
/* AU program "yw-stability-test" */ 
/* used with pulse sequence "zgps_hyper_cest" */ 
 
#include <stdlib.h> 
char *envpnt; 
int expTime, zgsafety, sleeptime = 20; 
int NumOfExp = 20; 
 
// GETINT ("Enter number of experiments :",NumOfExp);  
// the above line is optional 
 
envpnt = getenv("UXNMR_SAFETY"); 
zgsafety = 0; 
if(envpnt != NULL) 
{ 
 if(strcasecmp(envpnt, "on") == 0) 
 { 
   zgsafety = 1; 
   CPR_exec("env set UXNMR_SAFETY=off", WAIT_TERM); 
 } 
} 
 
GETCURDATA; 
WPAR("cest_yw","all"); 
 
// collect three null points in the beginning as variability is 
usually observed when delivery is first initiated 
// the expnos of these three null points follow the last valid data 
point 
 
WRA(NumOfExp + 1); 
REXPNO(NumOfExp + 1); 
 
// acquire three null points 
TIMES(3) 
    system("closeall.exe"); 
    sleep(sleeptime); 
    SETCURDATA; 
    RPAR("CEST_yw","all"); 
    system("openall.exe"); 
    ZG; 
  
 // auto process current data 
 EFP; 
 APK; 
 XCMD("abs n"); 
 APK; 
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 XCMD("abs n"); 
 APK; 
 XCMD("abs n"); 
  
 // go to next data set 
    IEXPNO; 
END 
 
// go to the beginning of dataset 
REXPNO(1); 
 
 
TIMES(NumOfExp) 
    system("closeall.exe"); 
    sleep(sleeptime); 
    SETCURDATA; 
    RPAR("cest_yw","all"); 
    system("openall.exe"); 
    ZG; 
  
 // auto process current data 
 EFP; 
 APK; 
 XCMD("abs n"); 
 APK; 
 XCMD("abs n"); 
 APK; 
 XCMD("abs n"); 
    IEXPNO; 
END 
 
if(zgsafety == 1) 
 CPR_exec("env set UXNMR_SAFETY=on", WAIT_TERM); 
 
QUITMSG("--- yw-stability-test finished ---"); 
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